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ABSTRACT 
 
RAJU YASHASWI PRASAD: Effect of the Nano-Bio Interface on the Genotoxicity of 
Titanium Dioxide Nanoparticles and Associated Cellular Responses 
(Under the direction of Rebecca C. Fry and David M. DeMarini) 
 
 
Several toxicological studies have shown that titanium dioxide nanoparticles (nano-
TiO2), one of the most widely produced engineered nanoparticles, can induce genotoxicity; 
however, potential adverse health effects associated with their physicochemical properties 
are not fully understood.  Proteins in a biological medium can adsorb to the surface of the 
nanoparticle resulting in the formation of a protein corona that can alter the physicochemical 
properties of the particle.  Furthermore, the protein corona may impact the interaction 
between nanoparticles and cells, referred to as the nano-bio interface, effecting the uptake, 
distribution, and toxicity of the particles.  Despite the potential influence of the composition 
of the biological medium on the physicochemical properties and genotoxicity of titanium 
dioxide nanoparticles, the majority of studies have not examined systematically the influence 
of medium composition on protein corona, genotoxicity, and cellular responses.  
 In this dissertation we tested the overall hypothesis that titanium dioxide 
nanoparticles in medium that produces the smallest agglomerates would be taken up into 
cells and induce genotoxicity, and that exposure would initiate the signaling of key mediators 
of a DNA damage and inflammation response.  Three major findings were shown in this 
study: 1) Protein corona formation on the surface of nano-TiO2 can impact the nano-bio 
interface and change cellular interaction.  2) Smaller agglomerates of nano-TiO2 are taken up 
iv 
	  
more by cells without inducing cell cycle arrest, thereby allowing induced DNA damage to 
be processed into micronuclei in BEAS-2B cells. 3) Nano-TiO2 in medium that facilitates 
increased cellular interaction induces the upregulation of the ATM-Chk2 DNA damage 
response (similar to ionizing radiation) and NF-κB inflammation pathways. 
Taken together, our research provides a systematic examination of the 
physicochemical properties, genotoxicity, and cellular responses induced by titanium dioxide 
nanoparticles.  The impact of cell type and cell culture conditions must be considered when 
analyzing in vitro studies for a health risk assessment of engineered nanoparticles.  
Therefore, we conclude that there is limited ability to make a general prediction regarding the 
in vitro genotoxicity of titanium dioxide nanoparticles without understanding further the 
toxicological implications of the nano-bio interface. 
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Chapter 1  
INTRODUCTION 
Nanotechnology has emerged as a strategy to address several issues in the consumer 
and medical industries due to the novel optical, electrical, and magnetic properties of 
nanomaterials, combined with their tunable size, shape and surface chemistry.  Although 
natural particulates in the size of nanometers are not new, manufactured or engineered 
nanoparticles are. They have been synthesized from metal and metal oxides such as titanium 
dioxide, silver, and copper oxide, as well as carbon derivatives such as fullerenes and carbon 
nanotubes. The current definition of engineered nanoparticles is a material having at least one 
dimension in the range of 1 - 100 nm and expressing novel properties (NIOSH 2005).  
The rapidly developing field of nanotechnology will result in increases in the 
inhalation, ingestion, skin uptake, and injection of engineered nanoparticles in humans.  
Therefore, information on the potential hazards of engineered nanoparticles is necessary for 
an appropriate safety evaluation.  Furthermore, environmental exposures that have been 
shown to cause these effects are linked to an increased risk of cancer (Wild 2009).  The 
multi-disciplinary field of nanotoxicology combines expertise in areas such as toxicology, 
materials science, medicine, molecular biology, and bioinformatics (Oberdorster et al., 2005).  
Throughout the early years of research in the field, the novel properties of nanoparticles, such 
as size, shape, and surface chemistry have been thought to contribute to the potential toxicity 
of nanoparticles (Card et al., 2008).  These physicochemical properties and their 
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accompanying toxicity profiles also vary greatly depending on the material.  Therefore, in 
identifying the risk associated with engineered nanoparticles, each type of nanoparticle must 
be analyzed individually using exposure assessment and toxicology protocols. 
Titanium dioxide nanoparticles (nano-TiO2) are being used primarily in consumer 
products, such as sunscreens and sporting goods as well as a photocatalyst in water to treat 
arsenic (NIOSH 2005, Yoon and Lee 2005), pathogens (Kim and Kwak 2009), organic 
pollutants, and inorganic pollutants (Ryu and Choi 2008, Shintre and Thakur 2009).  This 
provides a multitude of avenues for human exposure (Figure 1).   
Understanding the biological implications of human exposure to engineered 
nanoparticles will be extremely important towards their safe development and use in 
consumer products.  The combined studies of this dissertation examine the physicochemical 
characteristics of titanium dioxide nanoparticles (nano-TiO2) and their subsequent impact on 
cellular interaction, genotoxicity, and biological response in different cell types representing 
human target organs.  An ultimate goal for this project is to increase the knowledge on the 
physicochemical characteristics of titanium dioxide nanoparticles in biological medium and 
the subsequent impact of the particles on genotoxicity and biological pathways.  These 
studies support future research in the understanding of engineered nanoparticles on public 
health.   
In the case of nano-TiO2, particle coating, surface area, agglomeration state, and 
crystalline form (anatase vs. rutile) are all properties that may affect toxicity (Oberdorster et 
al., 2006).  Investigations into the fate, transport and biological response of nanoparticles in 
the body have yielded hypotheses of direct and indirect mechanisms of action.  The direct 
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mechanism involves passive diffusion, receptor-mediated endocytosis, and clathrin-coated 
vesicles as transportation mechanisms into the cell, wherein the nanoparticles can physically 
interact with the cellular machinery (Singh et al., 2009).  Indirect mechanisms involve cell-
surface contact and/or release of free metal ions, thereby initiating biological pathways such 
as oxidative stress and inflammation that may eventually lead to DNA damage (Bhattacharya 
et al., 2009; Hussain et al., 2009).   The current study examines aspects of these two 
mechanisms for nano-TiO2.   
With the burgeoning applications of nanotechnology in the consumer industry, the 
impact of engineered nanoparticles on human health require further examination.  The 
significance of this study stems from: 
(i) the applications of nano-TiO2 in water and sunscreens and potential for 
human exposure,  
(ii) the current lack of regulation regarding the use of nano-TiO2 in consumer 
products,  
(iii) previous in vitro and in vivo studies yielding inconclusive results on the 
genotoxicity of nano-TiO2 exposure,  
(iv) the need to investigate further the mechanisms of biological response to 
nano-TiO2 exposure such as genotoxicity, DNA damage response, and 
inflammation, and 
(v) the lack of information on the influence of physicochemical characteristics 
on the toxicity of these particles to guide safety assessment. 
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1.1 POTENTIAL FOR HUMAN EXPOSURE TO NANO-TIO2 IN THE ENVIRONMENT 
	  
The characteristics of nano-TiO2 make it useful for functional purposes such as the 
treatment of water containing arsenic as well as UV absorption in consumer products such as 
sunscreens.  However, exposing nano-TiO2 to the body through several routes, such as 
ingestion, inhalation, and absorption into the skin, could result in toxic effects.   
The literature on the effects of nano-TiO2 on drinking water treatment revolve around 
the photocatalytic treatment of As(III) into As(V), which is more easily removed due to 
lower solubility (Dutta et al., 2004).  Li et al. (2009) used nano-TiO2 as a treatment for 
removal of an arsenic species in drinking water.  The investigators modified the nanoparticle 
with palladium and nitrogen and used the particle with and without exposure to visible light.  
Their results showed that exposure to light for 1 h reduced the concentration of As(III) in 
water by over two orders of magnitude in water.  This level was below the U.S. 
Environmental Protection Agency standard of 10 µg/L.  The mechanism for this 
photocatalytic treatment is thought to involve hydroxyl radicals (Sharma and Sohn 2009).      
The ability of nano-TiO2 to photo-catalytically degrade various forms of arsenic was 
reported by Xu et al. (2008, 2009).  In their studies they show that in the presence of UV 
irradiation and TiO2, 93% monomethylarsonic acid (MMA) was transformed to inorganic 
arsenate [As(V)] after 72 h (Xu et al., 2008). The same group also showed adsorption of 
methylated arsenic species in TiO2 suspensions (Xu et al., 2009).  Dimethylarsenic (DMA) 
was degraded as well upon photocatalysis with MMA as the primary oxidation product.   
A similar study on the adsorption mechanism of arsenic on nanocrystalline TiO2 was 
conducted by Pena et al. (2006) using electrophoretic mobility measurements (Pena et al., 
5 
	  
2006).  They found that both As(V) and As(III) form bidentate binuclear surface complexes 
with TiO2.  The authors suggested that TiO2 was an effective adsorbent for arsenic removal 
due to its high surface area and high affinity hydroxyl groups.  
The ability of nano-TiO2 for water purification can also extend to other organic and 
inorganic pollutants.  Kabra et al. (2004) has documented the use of nano-TiO2 to degrade 
organic compounds and reduce toxic metal ions in aqueous solutions under UV light.  A 
study by Asahi et al. (2001) showed that nitrogen-doped nano-TiO2 was capable of 
photodegradating methylene blue under visible light.  With the potential economic impact of 
cleaning hazardous waste sites reaching up to $250 billion, it will be important to develop 
new technologies for cleanup that may include the use of engineered nanoparticles such as 
nano-TiO2 (Karn et al., 2009)  
Nano-TiO2 has become an ingredient in sunscreen because of its transparent 
appearance, high refractive index, and absorption/scattering of UV light.  Whereas 
conventional TiO2 scatters visible light and maintains a white appearance on skin, nano-TiO2 
scatters less visible light and appears transparent.  Studies have tried to assess the number 
and size of nanoparticles that are released from aerosolized sunscreens in order to gauge a 
real-world exposure to nano-TiO2.  Lewicka et al. (2011) isolated nano-TiO2 from eight 
commercial suncare products using three extraction methods.  They measured the dimension, 
shape, crystal structure, surface area, and composition of each nanoparticle formulation.  
Nano-TiO2 pigments were generally rutile nanocrystals of approximately 25 nm in size and 
needle-like or spherical shapes.  Furthermore, they determined that sunscreens consisted of a 
loose agglomeration of particles.  This suggests that rubbing sunscreen on human skin may 
break up these loose agglomerates and expose the skin to smaller particles.  In addition, a 
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potential dermal exposure may also occur due to sunscreen wash-off into water during 
swimming or bathing.     
The properties of high surface area-to-volume ratio and high affinity hydroxyl groups 
have been hypothesized to be a mechanism (free radical formation in the presence and/or 
absence of UV lights) by which nano-TiO2 could induce toxicity (Fenoglio et al., 2009; Madl 
and Pinkerton 2009).  Due to the increasing usage of nano-TiO2 in consumer products and 
water treatment procedures, it is important to determine the potential for real-world exposure 
and whether or not current regulations are sufficient in dealing with the added complexity of 
smaller sized particles.  The improvement of characterization of nano-TiO2 in consumer 
products, the factors that affect their presentation upon exposure, and life cycle analysis are 
extremely important in assessing the exposure to nanoparticles and their potential health 
effects.    
1.2 OCCUPATIONAL EXPOSURE TO NANO-TIO2 AND EXPOSURE 
RECOMMENDATIONS  
	  
The National Institute of Occupational Safety and Health (NIOSH) has listed a 
recommendation for ultrafine TiO2 particles at “0.3 mg/m3 for up to 10 hr/day during a 40-hr 
work week” (NIOSH 2009).  Gangwal et al. (2011) analyzed the short-term (24 h) and long-
term (working lifetime) exposure to silver nanoparticles and nanoTiO2 to determine 
appropriate concentrations for in vitro studies.  As they outline in a comment (Gangwal and 
Hubal 2012), there is sparse information on nanoparticle exposures, with the majority of their 
algorithm parameters coming from a report by the International Commission of Radiological 
Protection in 1994 (ICRP 1994).  However, using published engineered nanoparticle 
concentrations measured in air in manufacturing and research & development, and a 
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multiple-path particle dosimetry model for the human lung, Gangwal et al. identifed alveolar 
retention for silver nanoparticles, carbon nanotubes, and nano-TiO2 for a working lifetime of 
45 years to be in the range of 30-400 µg/ml, which they considered suitable for in vitro 
testing. 
The amount of nano-TiO2 that a person is exposed to in a real-world scenario is 
dependent on a variety of factors, such as activity level, occupational exposure, and use of 
consumer products that contain nanoparticles.  Furthermore, the concentrations that are 
relevant to human exposure levels have not yet been determined fully, and regulations have 
not been set.  Currently, the U.S. Food and Drug Administration (FDA) regulation is at 25% 
maximum concentration of TiO2 in sunscreen, but doesn’t call for specific characteristics 
such as crystal structure, coating, or size (FDA 1999). A case study by the U.S. 
Environmental Protection Agency (U.S. EPA) suggests that some sunscreens contain nano-
TiO2 at a range from 2-15%, but has not regulated on its usage (U.S. EPA 2010).  The 
International Agency for Research on Cancer (IARC) has currently labeled titanium dioxide 
a Group 2B carcinogen, or possibly carcinogenic to humans, but does not specify the  
physicochemical properties that would be hazardous versus those that would not.  The need 
for an appropriate safety evaluation and regulatory measures to permit a careful risk 
assessment of nano-TiO2 is paramount for the protection of public health.   For this to occur, 
the mechanisms of toxicity, if any, must be investigated.  The goal of this dissertation is to 
ascertain the toxicity of nano-TiO2 in different cell types representing potential exposure 
targets (lung, liver, skin) via sunscreens and water.  
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1.3 EPIDEMIOLOGY STUDIES ON TITANIUM DIOXIDE 
	  
To assess the literature on the effects of nano-TiO2, it is important to understand the 
results of epidemiologic studies.  Studies that have examined occupational exposures of 
workers to pigment-grade (<2.5 µm) TiO2 have not found an association with increased 
incidence of lung cancer (Fryzek et al., 2003; Boffetta et al., 2004).  Boffetta et al. (2004) 
studied 15, 017 workers (14,331 men) and found an increased standardized mortality ratio 
(SMR) of lung cancer; however, it was not associated with employment duration or estimated 
cumulative TiO2 exposure.  Fryzek et al. (Fryzek et al., 2003) studied 4,241 TiO2 workers 
employed for at least 6 months and found no significant trends or exposure-risk associations 
for total cancers, lung cancers, or other causes of death.  However, these studies made no 
association between particle sizes of TiO2 and effects.  Epidemiological studies are needed to 
assess accurately the carcinogenic risk to humans of nano-TiO2.  Additional studies 
examining biomarkers of exposure and physicochemical characteristics of the particles (i.e. 
size, shape, surface chemistry) that correlate to adverse outcomes would further the 
knowledge on nano-TiO2 exposure.  It is a goal of our study to understand the 
physicochemical properties of nano-TiO2 in biological medium that may influence the 
toxicity of nano-TiO2.     
1.4 GENOTOXICITY OF NANO-TIO2  
	  
Understanding the relationship between real-world exposures and test concentrations 
of nano-TiO2 will facilitate the interpretation of toxicology studies for interpreting 
mechanisms of action for risk assessment.  An important measure for regulatory purposes is 
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the potential genotoxicity of a toxicant.  By measuring genotoxicity, a mechanism of 
potential mutagenesis and carcinogenicity can be elucidated.   
The primary focus of research published on nano-TiO2 has been on the potential of 
nano-TiO2 to induce genotoxicity.  However, the results of these studies are conflicting and 
also vary in the physicochemical characterization, cell line, and cell culture medium used to 
assess these effects.  Overall, studies range from cell culture in human cell lines to animal 
studies involving various routes of exposure (inhalation, intratracheal instillation, 
intraperitoneal injection, etc.) and target tissues (lung, liver, skin, etc.).  
A review of the epidemiology literature by Roller (2009) states that, “For 
intentionally produced nanomaterials there is simply no adequate epidemiological 
information to conclude whether or not there is an association between exposure and lung 
cancer risk.”  With the growing application of engineered nanoparticles, the potential for 
human exposure is undeniable.  Therefore, the need to establish a consensus on testing, 
characterization, and toxicological effects in epidemiology, in vivo, and in vitro models are 
necessary to determine the degree to which engineered nanoparticles (in the particular case of 
this set of studies, nano-TiO2) can and should be regulated.  Our study attempts to understand 
further the impact of the preparation of nano-TiO2 in treatment medium and cell culture 
medium for experimental testing.    
1.5 IN VIVO CARCINOGENICITY AND GENOTOXICITY STUDIES  
	  
Animal studies on the genotoxicity of nano-TiO2 have also given conflicting results.  
Currently, the International Agency for Research on Cancer (IARC) has classified TiO2 as a 
group 2B (possibly carcinogenic to humans) primarily because of the results of two in vivo 
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studies in which high-pigment grade (<2.5 µm) and ultrafine TiO2 (<100 nm) dust particles 
were shown to cause respiratory tract cancer in exposed rats, one observed an excess 
incidence in both sexes and another in females only (Borm et al., 2004; Dankovic et al., 
2007; IARC 2010).  
Lee et al. (1985) examined groups of 100 male and 100 female rats at 5 weeks of age 
exposed by inhalation to titanium dioxide at concentrations of 0, 10, 50, or 250 mg/m3 for 6 
h/day on 5 day/week for 2 years.  The incidence of lung tumors was increased in both sexes 
in the high-dose rats (adenomas: male 12/77, female 13/74; squamous-cell carcinomas: male 
1/77, female 13/74).  The squamous-cell carcinomas were re-evaluated and 11 were 
described as non-neoplastic pulmonary keratinizing cysts (Warheit and Frame, 2006).  It 
should be noted in this study that the titanium dioxide was not nano-sized. 
Heinrich et al. (1995) reported on lung tumor incidences in rats and mice that inhaled 
photocatalytic TiO2.  For 100 female Wistar rats, nano-TiO2 exposure was stopped after 24 
months, and the animals were given clean air for 6 months.  At the end of the study, 32 of 
100 nano-TiO2 exposed rats had benign or malignant lung tumors, whereas only 1 of 217 
control rats had lung adenocarcinoma.  Heinrich et al. also exposed mice to ultrafine TiO2, 
and found that inhaling ~10 mg/m3 (7.2 mg/m3 for the first 4 months, then 14.8 mg/m3 for 4 
months, and 9.4 mg/m3 for 16 months) at 18 h/day for up to 24 months decreased 
significantly their lifespan (~50% mortality rate in titanium dioxide treated group versus 20% 
in control group after 17 months).  However, the reported spontaneous lung tumor frequency 
was not considered as significantly higher than that of the historical controls.  This may have 
been due to a decreased sensitivity because of the 25%/15.4% adenomas/adenocarcinoma 
rate in the controls.   
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Intra-peritoneally injected Wistar and Sprague-Dawley rats with photocatalytic nano-
TiO2 were examined for tumors in the abdomen (Pott et al., 1987).  Tumor incidences in the 
abdominal cavity ranged from 0-10% in the experiments in response to 5 injections of 20 mg 
nano-TiO2 over 5 weeks.  The authors concluded that there were no increases in tumor 
incidence in the treated rats.  Similarly, Hansen et al. (2006) did not observe tumors in rats 
that received subcutaneous intramuscular implantations of nano-TiO2 for up to twelve 
months.  However, granuloma (localized nodular inflammation) was observed at the site of 
implantation at 6 and 12 months post-implantation.  
A study on the genotoxicity of nano-TiO2 performed by Trouiller et al. (2009) examined 
the effect of 60-600 µg/ml of nano-TiO2 in the drinking water of mice.  The mice were 
allowed to drink freely for 5 days, and the measured intake produced exposures in the range 
of 50-500 mg/kg.  The endpoints included several markers of DNA damage and chromosome 
breakage including the comet and micronucleus assays performed in peripheral blood, 
γH2AX assay in bone marrow cells, and 8-OH-dG formation in livers isolated just after five 
days of treatment.  They found increases in all of the DNA damage markers (with γH2AX 
being the most sensitive- significantly elevated at all concentrations tested) in addition to an 
inflammatory response (assessed by expression of TNF-α, IFN-γ and IL-8) in peripheral 
blood.  This study indicated that exposure to nano-TiO2 in drinking water was genotoxic in 
mice.      
1.6 IN VITRO GENOTOXICITY STUDIES  
	  
The in vitro genotoxicity studies involving nano-TiO2 involve several different assays 
to detect DNA damage.  However, some of the studies are contradictory and a clearer 
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understanding is needed.  Most of the early studies used two common methodologies: the 
alkaline comet assay for DNA strand breaks and the cytokinesis-blocked micronucleus assay 
for chromosome breakage/loss.  Other assays have been used as markers of DNA damage, 
such as the phosphorylation of H2AX and Hprt mutation assay, however, not nearly as often.  
Below is a detailed examination of the in vitro genotoxicity of nano-TiO2 (see Appendix A 
for a summary table of genotoxicity studies in mammalian cell types).  Our study examines 
the in vitro genotoxicity of nano-TiO2 and attempts to address knowledge gaps in the 
literature related to physicochemical characterization and cellular responses. 
One of the earliest in vitro studies of nano-TiO2 genotoxicity was conducted by Gurr 
et al. (2005).  In this study they examined nano-TiO2 in the absence of photoactivation in 
human bronchial epithelial cells (BEAS-2B).  They found that anatase-sized TiO2 particles in 
the nano range (10 and 20 nm) induced oxidative DNA damage, lipid peroxidation, 
micronuclei formation, and increased hydrogen peroxide and nitric oxide production.  
However, larger sized particles (200 nm) did not increase DNA damage markers.  The results 
suggest that nano-TiO2 can cause an inflammatory response and oxidative DNA damage 
regardless of the presence/absence of photoactivation, and that it may be size related.  A 
limitation of this study, not to mention several of the early nanoparticle studies, is the lack of 
physicochemical characterization of the nanoparticle in the dry form as well as the cell 
culture medium.  After publication of several studies that provided toxicological information 
but no physical characterization, Warheit et al. (2008) suggested a requirement to report the 
characterization of the properties of each nanoparticle in order to link toxicity with certain 
physicochemical characteristics. 
13 
	  
Another in vitro experiment that examined toxicity and oxidative stress response 
elicited by nano-TiO2 was Park et al. (2008).  Exposure of cultured cells led to cell death, 
reactive oxygen species (ROS), reduced glutathione, and the induction of oxidative stress-
related genes such as heme oxygenase-1, thioredoxin reductase, glutathione-S-transferase, 
catalase and a hypoxia inducible gene.  Inflammatory proteins were upregulated, including 
IL-8, which the authors showed to be induced by the p38 MAPK and/or ERK pathways.  
A study of human peripheral blood lymphocytes exposed to nano-TiO2 was 
performed by Kang et al. (2008).  In addition to confirming DNA strand breakage and 
micronucleus induction, they identified an accumulation of p53 and activation of DNA 
damage checkpoint kinases.  They also saw generation of reactive oxygen species that was 
confirmed through inhibition by N-acetylcysteine (NAC).  This study found a cellular 
cascade involving p53 that was affected by nano-TiO2 treatment.   
A thorough examination of the cytotoxicity and genotoxicity of nano-TiO2 in WIL2-
NS cells (lymphoblasts) treated at 6, 24 and 48 h with concentrations of 0, 26, 65, and 130 
µg/ml was reported by Wang et al. (2007).  A significant decrease in viability was seen at 
higher doses, along with increases in the frequency of micronuclei.  The comet assay, which 
assesses DNA strand breaks, showed a 5-fold increase at 65 µg/ml.  Lastly, increases in 
mutant frequency as assessed by the Hprt mutation assay were shown with 130 µg/ml.  The 
results further suggest that nano-TiO2 can cause genotoxicity and cytotoxicity in human cells. 
Rahman et al. (2002) investigated the ability for nano-TiO2 greater than 20 nm to 
cause chromosome breakage by micronucleus formation at several concentrations (0.5, 1, 5, 
and 10 µg/cm2) in Syrian hamster embryo fibroblasts at various time points (12, 24, 48, 66, 
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72 h).  They found that micronuclei frequency was significantly elevated from control at 1 
µg/cm2 at each time point.  Additionally, they found that the micronuclei were kinetochore-
negative, which means that nano-TiO2 caused chromosome breakage rather than aneuploidy.  
ROS is a common hypothesis for the mechanism of engineered nanoparticle toxicity.  
Shukla et al. (2011) examined the potential of nano-TiO2 to induce ROS-mediated 
genotoxicity as measured by the comet and micronucleus assay in human epidermal cells.  
Additonally, they showed a positive correlation (using regression analysis) between ROS-
production and increases in micronucleus formation and oxidative DNA damage production 
using the formamidopyrimidine DNA glycosylase (Fpg) enzyme, which specifically 
recognizes oxidative DNA damage.       
The combination of UV and nano-TiO2 co-exposure is relevant because of the 
application of nano-TiO2 in sunscreens, mostly as an active ingredient (Weir et al., 2012).  
Reeves et al. (2008) studied the effects of UV-exposure on 5 nm nano-TiO2 in GFSk-S1 
(goldfish skin cells) on cytotoxicity and DNA damage using the comet assay.  For 
cytotoxicity, the authors used the neutral red assay and found that with UV-A exposure (0.5-
2.0 kJ/m2), nano-TiO2 caused a dose-dependent decrease (0.1-1000 µg/ml) in cytotoxicity, 
but without UV-A exposure no cytotoxicity was seen (24-h time point).  Furthermore, Fpg-
sensitive DNA damage (indicative of oxidative stress-induced damage) was seen at 10 µg/ml 
at 2 h and 100 µg/ml at 24 h without UV-A exposure, and UV-A irradiation caused further 
DNA damage.  The authors concluded that the hydroxyl radical was associated with nano-
TiO2-induced cytotoxicity and oxidative DNA damage.   
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In the midst of all the positive in vitro data on the genotoxicity of nano-TiO2, both 
Bhattacharya et al. (2009) and Hackenberg et al. (2009) did not find any DNA damage 
induced by nano-TiO2 with the comet assay in IMR-90/BEAS-2B cells or peripheral blood 
lymphocytes, respectively.  Furthermore, neither study observed much cytotoxicity in the 
cells as well.  Bhattacharya et al. did note an increase in DNA adduct formation (8-OH-dG) 
with nano-TiO2 exposures of 5 and 10 µg/cm2 and also saw increases in the production of 
reactive oxygen species at 10 and 50 µg/cm2 at 6, 12, and 24 h.  These studies contribute to 
the ongoing debate over the genotoxicity of nano-TiO2.  
A study using nano-TiO2 with both anatase (<25 nm in dry form) and rutile (<5 nm in 
dry form) in BEAS-2B cells similar to Gurr et al. (2005) was performed by Falck et al. 
(2009).  The difference in their studies is in the cellular medium: Gurr et al. used LHC-9 
supplemented with 10% FBS, whereas Falck et al. used BEGM defined medium with no 
serum.  TEM characterization was used in Falck et al. (no physicochemical characterization 
in Gurr et al. was done) to show that the average agglomerate sizes in the cell culture 
medium was ~4.5 µm for the rutile nano-TiO2 and ~5.5 µm for the anatase nano-TiO2.  The 
cytotoxicity and genotoxicity endpoints from Falck et al. differ from those in Gurr et al.  In 
Falck et al., cytotoxicity as measured by trypan blue dye exclusion for cytotoxicity was 
found to be significant at a concentration of 160 µg/cm2 at 48 and 72 h (but not at 24 h).  The 
comet assay was significantly elevated at 24 h at 80 µg/cm2 only.  Micronucleus formation 
was observed only at 72 h (not at 24 or 48 h) at 10 and 60 µg/cm2. Why are there differences 
in these seemingly similar studies using nano-TiO2 in BEAS-2B cells?  One hypothesis is 
that since Falck et al. used a serum-free BEGM medium and Gurr et al. used LHC-9 with 
10% fetal bovine serum, the biological medium components impacted the properties of nano-
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TiO2 and subsequently its genotoxicity.  The impact of biological medium on the 
physicochemical properties of nano-TiO2 and the subsequent effect on genotoxicity in human 
cell culture is a primary aim of this study.  Furthermore, the impact of the biological medium 
on the toxicity of nano-TiO2 may help to predict more accurately the in vivo toxicity of these 
nanoparticles. 
The body of literature on the toxicological effects of nano-TiO2 is still incomplete.  
The inconsistencies in reporting on physicochemical characteristics as well as the differences 
in biological endpoints in vitro and in vivo underscore the need for further testing.  
Comprehensive studies that elucidate further the complexities of the novel properties of 
engineered nanoparticles and the ability to elicit toxicological effects are paramount to 
advancing the field.  
1.7 NANO-BIO INTERACTIONS  
	  
Several studies suggest that a nanoparticle-protein interaction, referred to as the 
protein corona, can occur when proteins attach to the surface of the nanoparticle.  This 
protein coating can become part of the surface that interacts with the cell membrane as in 
Figure 2 (Nel et al., 2009; Maiorano et al., 2011).  This interaction has been shown to play a 
role in the physicochemical characteristics of nanoparticles and play a role in the cellular 
uptake, gene expression, and toxicity of engineered nanoparticles (Albanese et al., 2012).  
Understanding this process is important for the design of nanoparticles for drug delivery and 
to understand the potential toxicity of nanoparticles.    
Previous in vitro studies have shown the influence of nanoparticle-protein interactions 
and toxicity.  For example, bovine serum albumin (BSA) and dipalmitoylphosphatidylcholine 
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(a surfactant lipid) increased the production of reactive oxygen species by carbon black 
particles (Foucaud et al., 2007), whereas Pluronic F127 (a surfactant) dispersion resulted in 
lower toxicity of single-walled carbon nanotunes and amorphous silica nanoparticles (Dutta 
et al., 2007); and fetal bovine serum (FBS) dispersion resulted in lower toxicity of gold 
nanorods (Hauck et al., 2008).  FBS also was shown to result in greater cellular uptake of 
nano-TiO2 in comparison to serum-free medium (Tedja et al., 2012). 
Depending on the compound, its size/shape, the route of exposure, and distribution 
within the body, engineered nanoparticles have the potential to interact with a variety of 
biological components, such as protein. This interaction can lead to the association of a 
protein corona that elicits a toxicological response by changing the nanoparticle-cell 
interaction.  Additionally, when including targeted ligands that have become important in the 
applicability of engineered nanoparticles to complex diseases, the protein corona may impede 
the efficacy and possibly induce off-target effects.    
One of the primary goals of the studies is to identify the role of the protein corona on 
the genotoxicity of nano-TiO2.  By adequate physicochemical characterization of nano-TiO2 
in both dry form and in various dispersions reflecting biological medium, we can identify 
which characteristics of nano-TiO2 can contribute to its genotoxicity and cellular response.  
1.8 CELLULAR RESPONSE TO NANO-TIO2  
	  
Several studies have identified toxicological signaling pathways to nano-TiO2 
exposure in vitro.  Zhao et al. (2009) found that titanium dioxide nanoparticles activated the 
pro-apoptotic pathways via activation of caspase-8, Bid, Bax, and caspase-3, as well as a 
decrease of Bcl-6 in JB6 cells.  In addition, they found cytochrome c release from the 
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mitochondria to the cytosol.  The levels of caspase-3 and caspase-9 in addition to Bax, 
cytochrome C, p53 and Bcl-2 were also shown to be upregulated in BEAS-2B cells (Shi et 
al., 2010a).  Both of these studies suggest nano-TiO2 induced apoptosis involving an intrinsic 
mitochondrial pathway. 
Wu et al., (2010) studied the effects of nano-TiO2 on cytotoxicity, cell cycle and 
biological pathways in PC12 (neuronal) cells.  They found an upregulation in JNK and p53 
as well as G2/M cell cycle arrest.  The authors suggest that reactive oxygen species were 
responsible for the activation of toxicity pathways.  The oxidative stress mechanism of 
toxicity was also shown in mice exposed to nano-TiO2 for 30 consecutive days (Wang et al., 
2011a).  The study showed increases in the expression of heme oxygenase-1 via the p38-Nrf-
2 signaling pathway.      
An argument has been made for using the biology of particle-induced oxidative stress 
as a basis for predictive modeling of engineered nanoparticle toxicity (Nel et al., 2006).  This 
hypothesis is due to the direct relationship between surface area, reactive oxygen species 
production, and inflammatory effects of nanoparticles that have been shown in the lung (Nel 
2005; Oberdorster et al., 2005).  In addition to an increased production of reactive oxygen 
species, studies by Jaeger et al. (2012) and Shukla et al. (2011b) have also shown significant 
decreases in the anti-oxidant glutathione and increased frequency of micronuclei after nano-
TiO2 exposure in HaCaT keratinocytes. These results suggest that increased production of 
reactive oxygen species may be a cause of the genotoxicity of nano-TiO2.  
 A study by Ge et al. (2011) analyzed proteomic changes in response to nano-TiO2 
exposure.  The authors identified key proteins involved in oxidative stress response in BEAS-
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2B cells, including catalase and superoxide dismutase.  Another study examining nano-TiO2 
exposure in human amnion epithelial (WISH) cells found a 1.87-fold increase in intracellular 
reactive oxygen species generation, significant reduction in catalase activity and glutathione 
levels, as well as an increase in G2/M cell cycle arrest and DNA double strand breaks with 
the neutral comet assay (Saquib et al., 2012).   
Identifying the cellular response to a toxicant is paramount in determining biomarkers 
of exposure as well as mechanisms of toxicity.  Investigation of signaling pathways can also 
reveal similarities and differences between toxicants.  Studies have indicated the role of 
reactive oxygen species in the toxicity of nano-TiO2.  Although nano-TiO2 has been shown to 
induce both reactive oxygen species and genotoxicity, their effect on inflammation and DNA 
damage response are not well defined.  In our study, we assess the role of the nano-bio 
interface on the potential for nano-TiO2 to induce genotoxicity and upregulate adverse 
outcome pathways of DNA damage response and inflammation. 
The primary goals of our study are to:  
(i) understand the physicochemical characteristics that can lead to the cellular 
interaction and genotoxicity of nano-TiO2,  
(ii) identify the cellular stress response to nano-TiO2 as represented by the 
DNA damage response and inflammation pathways and  
(iii) use an integrated approach to examine the effects of nano-TiO2 on different 
organs using three cell lines representing the lung, skin and liver. 
In chapter 2, we analyze the effects of three treatment media differentiated by protein 
supplementation and concentration (bovine serum albumin, bovine serum albumin plus 
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surfactant, and fetal bovine serum) on the agglomeration of nano-TiO2.  We examine further 
the genotoxicity, cellular interaction, and cell cycle differences in human lung epithelial 
(BEAS-2B) cells.  In chapter 3, we build upon the results of chapter 2 by investigating the 
DNA damage response to nano-TiO2 in human dermal fibroblasts using two known 
genotoxic pathways associated with: (i) ultraviolet light: ataxia telangiectasia mutated and 
Rad3 related (ATR) and its downstream kinase checkpoint kinase 1 (Chk1) and (ii) ionizing 
radiation: ataxia telangiectasia mutated (ATM) and its downstream kinase checkpoint kinase 
2 (Chk2).  In chapter 4, we analyze two treatment media (one supplemented with bovine 
serum albumin and the other with fetal bovine serum) and its’ subsequent impact on 
agglomeration, genotoxicity, and cellular interaction in a human hepatoma (HepG2) cell line.  
Additionally we analyze the key mediators of DNA damage response (ATM) and 
inflammation.   
By adequate physical characterization in dry form and dispersion (agglomeration, 
zeta potential, nanoparticle-protein interaction, and cellular interaction), we aim to provide a 
systematic assessment of nanoparticle physicochemical characterization, interaction with the 
cell, and impact on genotoxicity in three different cell lines representing three target organs.  
Subsequently, we intend to examine the biological response to nano-TiO2 in three different 
cell types.   
1.9 SPECIFIC AIMS 
	  
The central hypothesis of this dissertation is that titanium dioxide nanoparticles in 
medium that produces the smallest agglomerates will be taken up into cells and induce 
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genotoxicity, and that upon exposure, cells will initiate signaling of key mediators of DNA 
damage and inflammation stress responses. 
This hypothesis will be tested using three specific aims: 
The goal of aim 1 is to determine whether nanoparticle-protein interactions influence 
the cellular uptake, cell-cycle, and genotoxicity of nano-TiO2 in human lung epithelial 
(BEAS-2B) cells. In the first aim, we propose to examine the effects of nanoparticle-protein 
interactions on cellular uptake, cell-cycle progression, and genotoxicity by creating three 
different dispersion media (serum-free media, media containing BSA and surfactant to mimic 
bronchoalveolar lavage fluid, and media with 10% fetal bovine serum).  We will use flow 
cytometry to assess cellular uptake and cell-cycle, the comet assay to assess DNA damage, 
and the micronucleus assay to determine chromosome damage.  The hypothesis of aim 1 is 
that nanoparticle-protein interactions that elicit the smallest aggregates will induce 
genotoxicity in human lung epithelial cells. 
The goal of aim 2 is to establish the effects on replication dynamics and DNA 
damage response of nano-TiO2 in human dermal fibroblasts.  In the second aim, we propose 
to assess DNA replication dynamics and new origin firing using DNA combed fibers, and the 
DNA damage response in human dermal fibroblasts following exposure to TiO2 
nanoparticles by analyzing phosphorylation of H2AX and DNA repair pathways (ATM-
Chk2, ATR-Chk1) using immunocytochemistry and western blotting.  The hypothesis of aim 
2 is that nano-TiO2 will induce a DNA damage response in human dermal fibroblasts. 
The goal of aim 3 is to confirm the role of nanoparticle-protein interactions on 
cellular uptake and genotoxicity, and assess the effects of nano-TiO2 on the adverse outcome 
pathways of oxidative stress and inflammation in human hepatoma cells. In the third aim, we 
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propose to confirm the role of nanoparticle-protein interactions on cellular uptake, 
genotoxicity, and DNA damage response shown in Aims 1 and 2 in human hepatoma cells.  
Further, we propose to assess cellular stress response pathways after TiO2 nanoparticle 
exposure by using a high-throughput reporter gene assay to determine transcriptional 
activation of pathways indicative of inflammation (AP1, NFkB).  The hypothesis of aim 3 is 
that nanoparticle-protein interactions that elicit the smallest aggregates will induce 
genotoxicity, a DNA damage response, and upregulate transcriptional activation of 
inflammation pathways in human hepatoma (HepG2) cells. 
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Chapter 2  
EFFECT OF TREATMENT MEDIA ON THE AGGLOMERATION OF TITANIUM 
DIOXIDE NANOPARTICLES: IMPACT ON GENOTOXICITY, CELLULAR 
INTERACTION, AND CELL CYCLE 
2.1 OVERVIEW 
The widespread use of titanium dioxide (TiO2) nanoparticles in consumer products 
increases the probability of exposure to humans and the environment.  Although TiO2 
nanoparticles have been shown to induce DNA damage (comet assay) and chromosome 
damage (micronucleus assay, MN) in vitro, no study has systematically assessed the 
influence of medium composition on the physicochemical characteristics and genotoxicity of 
TiO2 nanoparticles.  We assessed TiO2 nanoparticle agglomeration, cellular interaction, 
induction of genotoxicity, and influence on cell cycle in human lung epithelial cells using 
three different nanoparticle-treatment media: keratinocyte growth medium (KGMTM) 
medium plus 0.1% bovine-serum albumin (KB); a synthetic broncheoalveolar lavage fluid 
containing PBS and 0.6% bovine-serum albumin and 0.001% surfactant (DM); or KGMTM 
with 10% fetal bovine serum (KF).  The comet assay showed that TiO2 nanoparticles induced 
similar amounts of DNA damage in all three media, independent of the amount of 
agglomeration, cellular interaction, or cell-cycle changes measured by flow cytometry.  In 
contrast, TiO2 nanoparticles induced MN only in KF, which is the medium that facilitated the 
lowest amount of agglomeration, the greatest amount of nanoparticle cellular interaction, and 
the highest population of cells accumulating in S phase.  These results with TiO2 
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nanoparticles in KF demonstrate an association between medium composition, particle 
uptake, and nanoparticle interaction with cells, leading to chromosomal damage as measured 
by the MN assay.     
2.2 INTRODUCTION 
	  
The number of consumer and commercial products containing nanoparticles already 
exceeds 800 and is growing at an exponential rate (Singh et al., 2009).  Metal oxide 
nanoparticles, in particular, are currently present in the environment due to industrial 
processes and consumer products available on the market (NIOSH 2011). This increased 
usage requires an improved understanding of the potential risks and hazards associated with 
human exposure.  Specifically, it is critically important to identify those physicochemical 
characteristics of nanoparticles that may cause detrimental health effects.   
 Titanium dioxide (TiO2) nanoparticles, which are one of the most widely used 
engineered nanoparticles, are used in sunscreens and cosmetics because of their absorptive 
properties, and have also been used as a wastewater disinfectant due to their photocatalytic 
properties (Singh et al., 2009).  The National Institute for Occupational Standards and Health 
has made efforts to determine two different size/concentration levels for worker safety due to 
the potential for nano-sized TiO2 particles to cause toxicity (NIOSH 2011). Furthermore, the 
crystal structure of TiO2 nanoparticles has been shown previously to play a role in the 
toxicity of such nanoparticles, with the anatase isoform inducing greater inflammation than 
the rutile isoform in vivo (Warheit et al., 2007).  
  Several studies over the last decade have used the single cell gel electrophoresis 
(comet) assay and cytokinesis-blocked micronucleus (MN) assay to investigate the in vitro 
25 
	  
genotoxicity of TiO2 nanoparticles. In some studies TiO2 nanoparticles showed no significant 
induction of DNA damage based on the comet assay in human peripheral blood lymphocytes	  
(Hackenberg et al., 2011) or BEAS-2B/IMR-90 cells (Bhattacharya et al., 2009). However, 
other studies found that TiO2 nanoparticles induced DNA damage in BEAS-2B (Falck et al., 
2009; Gurr et al., 2005), GFSk-S1 cells (Hackenberg et al., 2010), and peripheral blood 
lymphocytes (Kang et al., 2008).	   Based on results with the MN assay, researchers have 
found that TiO2 nanoparticles induce chromosomal damage in BEAS-2B cells at 24 h (Gurr 
et al., 2005); in SHE fibroblasts at 12, 24, 48, 66, and 72 h (Rahman et al., 2002); in WIL2-
NS cells at 6, 24, and 48 h (Wang et al., 2007); and in peripheral blood lymphocytes in vitro 
at 12, 24, and, 48 h (Kang et al., 2008).  However, another study in BEAS-2B cells showed a 
significant increase in MN only after a 72-h exposure but not after a 24- or 48-h exposure 
(Falck et al., 2009).   
A potential explanation for this discrepancy is in the preparation of the nanoparticles 
as well as the type of medium in which the cells are cultured and/or treated.  Nanoparticle-
protein interactions (referred to as the “protein corona” or the association of proteins in a 
biological medium with the surface of the nanoparticle) have been hypothesized to play an 
important role in the uptake, distribution, and toxicity of nanoparticles in biological systems; 
however, it is still unclear how this occurs (Dutta et al., 2007; Lundqvist et al., 2008; Nel et 
al., 2009; Maiorano et al., 2010; Monopoli et al., 2011;).    For example, reactive-oxygen 
species (ROS) produced by exposure to carbon black particles in a Monomac-6 cell line were 
increased when medium containing 1% bovine serum albumin (BSA) and/or 0.025% 
surfactant was used (Foucaud et al., 2007).   A surfactant (Pluronic F127) used to disperse 
single-walled carbon nanotubes and amorphous silica resulted in a lower toxicity in RAW 
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264.7, a macrophage-like cell line (Dutta et al., 2007).  Gold nanorods induced less toxicity 
in HeLa cells when serum was used in the cell-culture medium, and this was associated with 
reduced cellular uptake (Hauck et al., 2008).    On the other hand, silica suspended in 
bronchoalveolar lavage (BAL) fluid showed no differences in the induction of pulmonary 
inflammation and lactate dehydrogenase in A549 (a human lung cell line) compared to a 
phosphate buffer solution (Sager et al., 2007).  
 Despite the apparent role of medium composition and other factors on the 
genotoxicity of TiO2 nanoparticles, no systematic assessment of these parameters has been 
performed (Gonzalez et al., 2008; Doak et al., 2009; Johnston et al., 2009; Donaldson et al., 
2010).  Consequently, there is no consensus or harmonized guidance on how to prepare 
nanoparticles for in vitro toxicity testing or to formulate the composition of the medium.  
Additionally, there is no consensus on what physicochemical characteristics of the particles 
should be determined and reported or for the physicochemical characteristics that may 
influence genotoxicity (Donaldson et al., 2010). Some genotoxicity studies have not 
characterized the nanoparticles in dispersion (Gurr et al., 2005); nonetheless, physical 
characteristics such as surface area, primary particle size, and agglomeration/stability of the 
dispersion are thought to play a role in the toxicity of nanoparticles (Wick et al., 2007; Stone 
et al.; 2009, Ji et al., 2010; Tenzer et al., 2011).    
The relationship between the protein corona and its role in genotoxicity is not fully 
understood (Donaldson et al., 2010). Cationic polysaccharide nanoparticles (60 nm) 
dispersed in serum, no serum, or BSA were shown to have differences in cellular uptake, 
DNA damage, and MN frequencies in 16HBE14o- human bronchial epithelial cells (Merhi et 
al., 2012).  Corradi et al.	  (2012) studied an array of nanoparticles (Lys-SiO2, TiO2, ZnO, and 
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multi-walled carbon nanotubes) in the presence or absence of 10% serum in A549 cells after 
a 4-h exposure and showed increases in MN frequency in cells treated with ZnO in the 
presence of serum.  Thus, there is a need to determine the most appropriate procedures by 
which to characterize TiO2 nanoparticles, to measure their uptake into cells, and to evaluate 
their genotoxicity in order to produce data useful for assessing the safety of nanoparticles 
(Maynard et al., 2006; Nel et al., 2006).	  
 To address this issue, we have determined the cytotoxicity and genotoxicity of 10-
100 µg/ml of TiO2 nanoparticles in human lung epithelial cells (BEAS-2B) exposed in three 
different media that have been used previously in nantoxicology studies (Dutta et al., 2007; 
Foucaud et al., 2007; Sager et al., 2007; Hauck et al., 2008).  We chose this concentration 
range to be consistent with previously published literature on the in vitro genotoxicity of 
TiO2 nanoparticles (Rahman et al., 2002; Gurr et al., 2005; Wang et al., 2007; Kang et al., 
2008; Bhattacharya et al., 2009; Falck et al., 2009; Hackenberg et al., 2010; Hackenberg et 
al., 2011).  We diluted and sonicated TiO2 nanoparticles in either (a) keratinocyte growth 
medium (KGMTM) with 0.1% BSA, referred to as KB, (b) a medium that mimics BAL by 
containing phosphate-buffered saline (PBS) with 0.6% BSA and 0.001% DSPC (1,2-
dipalmitoyl-sn-glycero-3-phosphocholine, a surfactant) as a biologically relevant medium 
that can also improve dispersion (Foucaud et al., 2007, Sager et al., 2007) and referred to 
herein as dispersion medium (DM), or (c) KGMTM with 10% fetal bovine serum (FBS) and 
referred to as KF.  These media compositions are those of the nanoparticle-treatment media.  
The cell-treatment media had lower levels of protein compared to the nanoparticle-treatment 
media, which were composed as follows:  KB was KGMTM + 0.01% BSA, DM was KGMTM 
alone, and KF was KGMTM + 1% FBS.  We characterized primary particle size, surface area, 
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purity, and crystal structure by transmission-electron microscopy (TEM) and visualized TiO2 
nanoparticles in each treatment medium with scanning electron microscopy (SEM). We also 
assessed whether proteins in each treatment medium were adsorbed to the nanoparticle 
surface using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).  
Lastly, we determined the hydrodynamic diameter/size, polydispersion index (PdI), and zeta 
potential by dynamic-light scattering (DLS), as well as cellular interaction and cell-cycle 
effects by flow cytometry (Zucker et al, 2010; Zucker et al., 2012).  
2.3 MATERIALS AND METHODS 
	  
2.3.1 Chemicals and Instruments 
The TiO2 nanoparticles (86% anatase and 14% rutile as listed by the manufacturer) 
were obtained from Degussa (now Evonik, AEROXIDE® TiO2 P25, Parsippany, NJ). 
Particles were sonicated using a probe sonicator (Cole Parmer, Vernon Hills, IL) and a 
Misonix S-4000 cup-horn sonicator (Cole Parmer).  Particle sizing and elemental analysis in 
the dry form was performed by TEM and ion-coupled plasmon mass spectrometry at the 
University of Kentucky (contract # PR-NC-08-10414) (Sanders et al., 2012). TiO2 
dispersions were characterized for hydrodynamic diameter and zeta potential by dynamic-
light scattering (DLS) using a ZetaSizer Nano (Malvern Instruments, Worcestershire, UK).   
The average particle size in the dry form was determined as an arithmetic mean of the 
measured diameters of approximately 150 particles.  Elemental analysis was performed by 
ICP/MS in duplicate, and specific-surface area was determined by BET (Sanders et al., 
2012).   
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We used three different nanoparticle-treatment media.  A medium with a low 
concentration of protein (KB) was composed of KGMTM (Lonza, Walkersville, MD) plus 
0.1% BSA (Sigma, St. Louis, MO).  The dispersion medium (DM) was composed of PBS 
supplemented with a moderate level of protein in the form of BSA at 6.0 mg/ml (0.6%) and 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DSPC) at 10 µg/ml (0.001%) and was 
purchased from Sigma-Aldrich.  A serum-containing medium (KF) was composed of 
KGMTM plus 10% FBS (Invitrogen). 
2.3.2 Particle Preparation 
For the KB or KF dispersion, pre-weighed TiO2 nanoparticles were suspended in 
KGMTM medium with 0.1% BSA (KB) or KGMTM with 10% FBS (KF) at 1 mg/ml and 
probe sonicated at 7 W for 2 min on ice; subsequent dilutions in KB and KF were made to 
500, 200, and 100 µg/ml.   
For the DM dispersion, the protocol of Porter et al. (Porter et al., 2008) was used with 
some modifications.  For the preparation of this treatment medium, stock concentrations of 
10 mg/ml DSPC was prepared in 100% ethanol, and BSA was made at a concentration of 10 
mg/ml.  The final concentration of BSA was 0.6% and that of DSPC was 0.001%.  The TiO2 
nanoparticles were suspended at a stock concentration of 1 mg/ml and sonicated using a cup-
horn sonicator at 78-82 W for 1 h using a 10-sec on, 10-sec off protocol.  Every 20 min, the 
samples were removed and vortexed to ensure a homogenous mixture.  The particles were 
then centrifuged at 12,000 x g for 10 min, the supernatant was aspirated, and the protein- and 
lipid-coated nanoparticles were resuspended in KGM™ medium.  Subsequent dilutions were 
performed in the same manner as were particles suspended in KB and KF.   
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2.3.3 Particle Characterization 
Nanoparticles were characterized in dry form using TEM (University of Kentucky) 
and in medium using DLS and zeta potential measurement techniques.  All nanomaterial 
preparations were diluted 1:10 in KGMTM and subjected to dynamic-light scattering analysis 
at 0 and 24 h for size and zeta potential measurements and calculations.  Approximately 1 ml 
of each concentration (0, 10, 20, 50, and 100 µg/ml) was placed in a sizing cuvette (Sarstedt, 
Nümbrecht, Germany) and measured by the Zetasizer Nano at 37 ºC (Malvern Instruments, 
Worcestershire, UK).  Intensity and PdI measurements at each concentration were at 0 and 24 
h.  The refractive index used for the measurements was 2.51, reflecting a 14% rutile, 86% 
anatase mixture.  Samples were placed in a humidified incubator at 37ºC between 
measurements.  For zeta potential each concentration was measured using a zeta-potential 
cuvette (Malvern Instruments, Worcestershire, UK) at 0-h time point only.  All particle 
characterization measurements are the mean ± SD of three independent experiments. 
2.3.4 Scanning Electron Microscopy 
Stock TiO2 nanoparticle suspensions were prepared as described previously in 
different treatment media at a concentration of 1 mg/ml.  Suspensions were then 
subsequently diluted 1:5 in PTFE-capped glass vials (VWR International, Morrisville, NC) 
using their original treatment media.  Diluted TiO2 nanoparticle suspensions were mixed, and 
5 µl of each sample were placed in the center of a pre-warmed (45-50°C) 0.2-µm nylon 
membrane filter (P/N 66600, 13-mm dia., Pall Life Sciences, Ann Arbor, MI) and allowed to 
dry rapidly.  Filters containing the various diluted nanoparticle samples were stored in glass 
Petri dishes treated for anti-static using Zerostat (Z108812-1EA, Zerostat anti-static 
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instrument, Sigma-Aldrich) at room temperature until analyzed by SEM.  SEM micrographs 
of nylon filters containing various nanoparticle-dispersion samples were obtained using the 
Phenom Tabletop SEM (Phenom-World NA, Inc., Beaverton, OR).  Briefly, nylon filters 
were mounted onto metal stubs using double-backed adhesive carbon tape.  The immobilized 
filter on the stubs was placed in the sample holder and the height adjusted so that the top of 
the filter was ~2 mm below the holder’s surface.  The holder was placed in the Phenom and 
loaded automatically.  At the low magnification, our detection limit is 100 nm without carbon 
coating; with carbon coating, the vendor specifies the lower-size limit as 30 nm.  
Magnification, focus, brightness/contrast, sample position, and image gathering were carried 
out by the use of an integrated touch screen and rotary-adjustment knob according to the 
manufacturer’s instructions. 
2.3.5 One-dimensional Gel Electrophoresis 
To determine the proteins adsorbed onto the surface of the TiO2 nanoparticles in each 
treatment medium, SDS-PAGE gel electrophoresis of the nanoparticles in each treatment 
medium, along with the treatment medium alone, was performed as described previously, 
with some modifications (Lundqvist et al., 2008, ; Maiorano et al., 2010; Tedja et al., 2012; 
Tedja et al., 2012a).  TiO2 nanoparticles were diluted in each treatment medium (KB, DM, 
and KF) at 1 mg/ml and sonicated as described previously.  After incubation for 24 h, 1 ml of 
each suspension was transferred to a separate tube and centrifuged at 12,000 x g for 15 
min.  The supernatant was aspirated, and the remaining pellets were washed with PBS and 
centrifuged again.  After the supernatant was removed, the TiO2 nanoparticles and equal 
volumes of each treatment medium were mixed with 2X Protein Gel Loading Buffer (Fisher 
Scientific) and heated at 95º C for 10 min.  All samples (treatment medium alone and 
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TiO2 nanoparticles in each treatment medium) were loaded onto 8-16% SDS-PAGE 1D gels 
(Thermo Scientific) along with a Fermentas PageRuler™ Plus protein ladder (Thermo 
Scientific), and a constant voltage of 125 V for 45 min was applied.  The gel was fixed with 
water for 15 min, stained using Gel Code Blue Stain (Thermo Scientific) for 3 h, followed by 
destaining with water for ~1 h.  Gel images were taken using a Gel Logic 2200 Pro imager 
and analyzed with MI SE 534 program (Carestream Health, Rochester, NY).  Three 
independent experiments were performed to ensure reproducibility.  A representative gel is 
shown in Supplemental Figure 5.  
2.3.6 Cell Treatment  
Cells at 5.0 x 104 cells/cm2 were seeded in T-25 flasks, incubated for 48 h, and then 
treated for 24 h with nanoparticles.  For these treatments, the new nanoparticle preparations 
(KB, DM, and KF) were diluted 1:10 in KGMTM to provide concentrations of 0, 10, 20 
(except for the comet assay), 50, and 100 µg/ml TiO2.  For the MN assay the cells were 
treated at ~60% confluence to ensure growth-phase characteristics, and fresh medium was 
added with the cytochalasin-B treatment.  For the comet assay the cells were treated at ~80% 
confluence.  
2.3.7 Cell Line and Cell Culture 
 BEAS-2B (ATCC), a human bronchial epithelial cell line, was maintained in serum-
free Keratinocyte Basal Medium (KBMTM, Lonza) supplemented with KGMTM 
SingleQuotsTM (Lonza) and used at passages 45-60.  BEAS-2B cells were infected with a 12-
SV40 adenovirus hybrid and cloned (ATCC).  Cells were seeded in T-25 tissue culture flasks 
at a cell density of 5 x 104 cells/cm2 and incubated in a fully humidified atmosphere at 37°C 
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with 5% CO2.  The cells were subcultured every 3-4 days or when they reached 85-90% 
confluency using HBSS (Lonza), Versene (Invitrogen), TrypLE (Invitrogen), and Trypsin 
Neutralizing Solution (Lonza).  Cells were centrifuged at 135 x g for 5 min, the supernatant 
was aspirated, and the cell pellet was re-suspended in fresh medium and brought to a 
concentration of 5 x 104 cells/cm2.  The cytochalasin-B was dissolved in PBS at 1 mg/ml.  
For the comet assay, SYBR-Gold was purchased from Molecular Probes (Eugene, OR) and 
diluted 1:200 in 1x TE buffer. 
2.3.8 Live/dead Assay 
 Calcein-AM and propidium iodide were purchased from Invitrogen (Carlsbad, CA).  
After cells were incubated in TiO2 in appropriate medium for 24 h in 25-cm2 flasks, the 
medium was aspirated and replaced with fresh medium containing calcein-AM (Invitrogen) 
and propidium iodide (Invitrogen) at a concentration of 1 µg/ml and placed in a humidified 
incubator at 37ºC and 5% CO2 for 1 h.  Images were taken of each concentration with 
WASABI imaging software (Hamamatsu) using an ORCA-ER camera (Hamamatsu) and a 
phase objective (Nikon, Plan 10X, na = 0.3), Nikon Diaphot 300 microscope with DAPI and 
FITC filters. Pictures were evaluated using a scoring grid placed on the captured images.  
Approximately 200 cells were counted in both Live (calcein+) and Dead (propidium iodide+) 
images (Supplemental Figure 6B).  Live/dead experiments were performed as three 
independent 24-h exposures for each treatment medium.  
2.3.9 Trypan Blue Dye-exclusion Assay 
Trypan blue was purchased from Sigma-Aldrich, and the trypan blue dye-exclusion 
assay was performed to measure the percent viable cells (Phillips 1973).  Briefly, after 
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treatment the cells were trypsinized, and 0.1 ml of the whole cell suspension was removed 
and placed in 0.5 ml of trypan blue and 0.4 ml of sterile PBS at a ratio of 1:10 for each 
treatment concentration.  Counts were performed with a hemocytometer where unstained 
cells were alive, and those that were stained blue were considered dead.  Trypan blue 
experiments were performed as three independent 24-h exposures for each treatment medium 
(Supplemental Figure 7).     
2.3.10 Flow Cytometry 
To determine cellular uptake by flow cytometry, the method of Zucker et al. (2010) 
was used.  Briefly, BEAS-2B cells were plated in twenty T-25 flasks (1×105 cells/ml) and 
incubated for 48 h.  After incubation, 10, 20, 50, and 100 µg/ml of TiO2 nanoparticles were 
prepared by sonication in 3 different media (KF, KB, and DM) as described previously.  The 
medium in each flask was replaced with 5 ml of nano-TiO2 suspension.  Each flask received 
treatment of TiO2 nanoparticles, and one control flask received only fresh medium.  
Following 24-h exposure, cells were trypsinized, centrifuged at 135 x g for 10 min, 
resuspended in 0.5 ml of medium, and put directly on ice.  Cellular uptake of TiO2 
nanoparticles was assessed in three independent experiments. 
A BD FACSCalibur™ (BD Biosciences, San Jose, CA) flow cytometer containing a 
488-nm laser, forward-scatter (FSC) diode detector, and photomultiplier tube side-scatter 
(SSC) detector was used in this study. Prior to each experiment, the instrument was checked 
for functionality and performance using Duke 3.0-µm alignment beads (Zucker 2008; 
Sanders et al., 2012).  The instrument yielded coefficient of variation values below 2% on all 
the fluorescence channels at low flow rates with Duke 3.0-µm alignment beads. The 
cytometer was set up to measure SSC logarithmically and FSC linearly. Most of the dynamic 
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ranges of the scales were used to optimize the changes with the different concentrations. The 
highest concentration of nanoparticles was run first to set the range for the maximum SSC 
signal and the minimum FSC signal. The treated values were normalized to control values 
and expressed as percent increase. 
2.3.11 Microscopy 
Dark-field microscopy has been used by us and others to visualize nanoparticle 
uptake into cells (Zucker et al., 2010, Zucker et al., 2012, Sanders et al., 2012, Zucker  and 
Daniel 2012, Hu et al., 2008, Cao et al., 2011, Weinkauf et al., 2009, Johnston et al., 2012, 
Thurn et al., 2011).  The cells in Figure 2C were spun onto a slide using a Shannon 
CytoSpinTM centrifuge at 40 x g for 5 min, fixed with 100% methanol, and stained using 40 
µg/ml acridine orange for 60 sec.  A Nikon E-800 microscope was used to observe dark-field 
and fluorescence images. The fluorescence excitation cubes consisted of FITC and TRITC.  
However, the dark-field image was so bright that it could be observed through either of the 
filter cubes. The dark field was ~100 times brighter than the fluorescence image as measured 
by exposure times. The combination of fluorescence and dark-field images was made 
sequentially with Nikon Elements software.  Co-localization was checked and measured with 
0.5-µm Tetra spec beads (Molecular Probes, Eugene, OR), and there was minimal distortion.  
A Xenon light supply was used to optimize the shorter wavelength excitation that provided 
for better resolution for the dark-field image. A GG420 filter was put in the eyepieces to 
protect the user’s eyes from possible UV damage from the Xenon light source. 
The most suitable Nikon lens when using a Nikon infinity-corrected microscope was 
a 60x Plan Fluor with an iris diaphragm to control the numerical aperture (NA) between 0.55 
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and 1.25. The lens had a sufficiently large magnification to observe cellular details and the 
background scatter, which could be controlled by adjusting the diaphragm.  During the 
course of this study, the dark-field images were obtained using the following dry lenses: Plan 
Apo 20x, (NA 0.75), and the following oil lenses: 20x multi-immersion (MI, NA 0.75), and 
60x Plan Fluor with iris (NA 1.25-0.55). 
2.3.12 Comet Assay 
 The comet assay was performed as described previously (Singh et al., 1991).  After 
treatment the cells were trypsinized and kept on ice throughout the duration of the slide 
preparation.  All nanoparticle concentrations examined resulted in cell viabilities above 80%.  
Briefly, 10 µl of cells at 106 cells/ml (approximately 10,000 cells) were added to 190 µl of 
0.53% low-melting-point agarose (LMP), and 90 µl were placed on two slides and covered 
by a 24- x 50-mm coverslip and placed on ice. After the agarose had solidified, the cover slip 
was removed, and another 90 µl of LMP was added, and a coverslip was placed on top.  The 
cover slip was removed again, and the slides were placed in 4ºC lysis buffer (5-M NaCl, 100-
mM EDTA, 10-mM Tris, 1% Triton X-100, pH 10.0) overnight at 4°C.  Following lysis, 
slides were rinsed with cold water and immersed in 4ºC denaturing electrophoresis buffer 
(300-mM NaOH, 1-mM EDTA) for 40 min. Electrophoresis was performed in cold buffer 
(pH > 13) for 20 min at 25 V (1.33 V/cm) and 300 mA.  Then the slides were immersed in 
neutralizing buffer (0.4-M Tris-HCl, pH 7.5) for 15 min, dehydrated in 95% ethanol for 3 
min, and allowed to air dry. 
 After drying, slides were stained with 5X Sybr Gold® and viewed using fluorescence 
microscopy.  Images were collected using the 25X objective (Plan Fluor 25X, Nikon 
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Microphot FXA), a Nikon B-2H filter, and an ORCA CCD camera (Hamamatsu) connected 
to a personal computer.   Images were analyzed using Komet® version 5.5 (Andor 
Technology, Morrisville, NC); 50 images per slide and two slides per concentration were 
analyzed in each experiment.  Slides were coded before analysis so that the scorer had no 
knowledge of the treatment when obtaining the data.  Data were expressed as the mean ± SD 
of three independent experiments for each treatment medium and concentration tested.  A 
representative image of undamaged and damaged cells is shown in Supplemental Figure 9.  
2.3.13 Cytokinesis-blocked MN Assay with Acridine-Orange Staining 
 The MN assay with acridine-orange staining was performed as described previously 
(Ellard and Parry 1993).  Cells treated with TiO2 nanoparticles for 24 h and then 5 µg/ml of 
cytochalasin B for 18 h were resuspended in PBS at a density of 2 x 105 cells/ml.  The cells 
from 75 µl of cell suspension were deposited onto pre-cleaned slides using a Shannon 
CytoSpinTM centrifuge at 40 x g for 5 min.  Slides were air dried, fixed in 100% methanol for 
10 min, and stored at 20ºC. 
 Slides were stained in acridine orange diluted to 40 µg/ml in a 0.02-M phosphate 
buffer (pH 7.4) for 30-45 sec and washed twice with distilled water.  A 24- x 55-cm cover 
glass was mounted using Sorenson’s buffer (70 ml 0.1-M NaHPO4 and 30 ml 0.1-M 
KH2PO4, pH=7.4).  Slides were scored blindly using a microscope (Nikon Microphot FXA), 
dual bandpass filter (TRITC/FITC), and 20X objective (Plan Fluor).  We examined 1000 
binucleated cells and scored for the presence of MN for each exposure.  Scoring criteria 
followed the recommendations of Fenech et al. (Fenech 2000).  Additionally, the CBPI was 
calculated for determination of cytostasis and as a marker of cytotoxicity (Kirsch-Volders et 
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al., 2003).  Two independent experiments were conducted for all concentrations in all three 
treatment media.   
2.3.14 Cell Cycle 
  For cell-cycle analysis BEAS-2B cells were treated with TiO2 nanoparticles for 24 h 
in the three different treatment media (KF, KB and DM), trypsinized, and placed on ice as 
described above.  Cells were then prepared for flow-cytometry analysis by incubating them 
for 15 min at 37°C with a 1:2 dilution in 0.5% NP-40 non-ionic detergent that was made up 
in PBS without Ca2+ and Mg2+.  The cells were then stained with propidium iodide (20 
µg/ml, Molecular Probes, Eugene OR).  The flow cytometer was set to measure nuclei using 
DNA FL2H (585/42) as the detection trigger.  Nuclei sub-populations were analyzed using 
MultiCycle (Phoenix Flow Systems, San Diego, CA) that was incorporated into FCS express 
4.0 (Denovo, Los Angeles, CA) analysis software. The percentage of cells in G1, S, and 
G2/M phases for all concentrations in each treatment medium were calculated from 
histograms using the area parameter.  Two independent experiments were performed and 
expressed as mean ± SD (Figure 6), and a representative experiment is shown in 
Supplemental Table 3.   
2.3.15 Statistical Analyses 
For statistical analyses, n equaled the number of replicate experiments, and results are 
presented as the mean ± SD.  Statistical analyses were carried out by using a one-tailed 
analysis of variance (ANOVA), where appropriate, followed by Fisher’s protected least-
significant-difference test for post-hoc comparisons to determine if the experimental 
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treatments produced differences among each other or from the controls.  Results were 
considered statistically significant if p < 0.05. 
In addition, for the comet assay, a linear model was used to compare the slopes of the 
3 regression lines (each treatment medium) for the induced DNA damage versus the square 
root of the concentration after a preliminary analysis for a best-fit model. The induced DNA 
damage (i.e., % tail DNA of each treated concentration minus mean % tail DNA for the 
concurrent controls) was used as a measure of damage to normalize the data because each 
replicate experiment was done at a different time.  The slopes of the regression lines were 
compared assuming a common Y-intercept set to zero using Statgraphics Centurion XVI 
Version 16.1.05 (Statpoint Technologies, Inc., Warrenton, VA).  For the MN assay simple 
linear-regression analyses were performed with StatGraphics Centurion XVI for each 
concentration-response curve for each medium.  For the two independent cell-cycle 
progression experiments for each medium, linear regression analysis was performed similar 
to that done by Potter et al. (Potter et al., 2002; Potter et al., 2005) but only on the change in 
percentage of cells in S phase.  If p < 0.05, then the regression was deemed significant, and 
the medium caused an effect on cell cycle.   
2.4 RESULTS 
	  
2.4.1 Physicochemical characterization of TiO2 nanoparticles in dry form and treatment 
medium.  
Determining the physical characteristics of nanoparticles in dry form and in treatment 
medium has become important in comparing studies across the literature (Gonzalez et al., 
2008; Johnston et al., 2009; Sayes and Warheit 2009).  The physical characteristics of 
Degussa P25 AEROXIDE® TiO2 in dry form were measured by TEM at the University of 
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Kentucky.  A representative image is shown in Appendix II Figure 1, and the results are 
presented in Table 1.  The primary particle size was measured to be ~27.5 nm, with a surface 
area of 49 m2/g, and the particles were a mixture of anatase and rutile crystal structures.  As 
illustrated by SEM in Figure 3, TiO2 nanoparticles were qualitatively different in all three 
treatment media.  The KF medium resulted in smaller agglomerated nanoparticles compared 
to those observed in the other two media.   
DLS was used to measure hydrodynamic diameter, PdI, and zeta potential of 
nanoparticles in suspension.  We initially measured each treatment medium alone and 
determined that the protein concentrations did not confound the DLS results (Appendix II 
Figure 2).  DLS measurements of TiO2 nanoparticles in the three treatment media showed 
that KB resulted in the largest agglomerates, followed by DM and then KF (Figure 4A).  
After 24 h at 37ºC, the suspension in KB showed larger agglomerates with increasing 
concentration from the 0-h size measurements, whereas KF did not.  DM showed slightly 
elevated agglomerates at 24 h, with a significant increase compared with KF.  Agglomerates 
in KB were still significantly greater than DM and KF after 24 h (Figure 4B). 
We also calculated the PdI, which is a measure of the variance in size measurements, 
for each concentration in each treatment medium (Table 2).  The values for all concentrations 
in all treatment media were between 0.2 and 0.8, with KB yielding the highest PdI values and 
KF yielding the lowest.  Zeta potential, a measure of electrokinetic potential that indicates the 
degree of repulsion between particles, was -0.53 mV to -8.47 mV for all concentrations in all 
treatment media at 37ºC (Table 2).  To be considered a disperse suspension these zeta 
potential values should be above/below ±30 mV (Renliang et al., 2007).  Thus, our results 
with both PdI and zeta potential indicate that the nanoparticle “dispersions” were unstable, 
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aggregating and separating out of the liquid phase during the genotoxicity experiments, 
which is common for medium suspensions of TiO2 nanoparticles (Ji et al., 2010).  Zeta 
potential of TiO2 nanoparticles in distilled water was lower than in medium, with a range of -
8.7 to -17.2 mV (indicating a more disperse suspension), which has been shown previously 
(Table 2) (Deng et al., 2009; Ji et al., 2010).  
2.4.2 Determination of cellular interaction   
 TiO2 nanoparticles can enter cells, resulting in a change in the cytoplasm that can be 
measured by flow cytometry using side scatter (Suzuki et al, 2007; Zucker et al., 2010; 
Zucker and Daniel 2012).  Thus, we assessed cellular interaction quantitatively and 
qualitatively by flow cytometry using a method developed in our laboratory (Zucker et al., 
2010; Zucker and Daniel 2012).  Figure 5A shows a representative side-scatter distribution 
for concentrations of 10-100 µg/ml of TiO2 nanoparticles in cells in each treatment medium.  
Side scatter is thought to indicate the cell granularity and mass of the cells (Shapiro 2001; 
Zucker 2008).  After treatment of the cells with TiO2 nanoparticles, there are increases in the 
side-scatter (90-degree direction) of the cells.   These values can be quantified using a ratio 
that compares the histogram of the treated population of cells to an untreated control (Figure 
5B).  There is a direct relationship between concentration of nanoparticles delivered to the 
cells and side scatter detected by the flow cytometer.  The data are presented as the ratio of 
the histogram means of the treated population to the control population.  This signal appears 
to be the result of both single and agglomerated nanoparticles located inside cells that 
increase the refractive index and, thus, the amount of side-scatter light.  Others and we have 
shown a direct relationship between the concentration of nanoparticles and the amount of 
light scatter measured by flow cytometry, and this relationship has also been confirmed by 
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dark-field microscopy (Shapiro 2001; Zucker 2008; Zucker et al., 2010; Zucker and Daniel 
2012).  
A representative dark-field microscopy image of a BEAS-2B cell after a 24-h 
exposure to TiO2 nanoparticles is shown in Figure 5C.  At high concentrations of TiO2 
nanoparticles (20-100 µg/ml), the cytoplasm appears to consist primarily of agglomerates.  
Microscopy has been used previously by our group and others to visualize nanoparticle 
interaction with cells (Shapiro 2001; Hu et al., 2008; Zucker 2008; Weinkauf et al., 2009; 
Johnston et al., 2010; Zucker et al., 2010; Cao et al., 2011; Sanders et al., 2012; Zucker and 
Daniel 2012).  It should be noted that the nanoparticles (colored white) are not located in or 
over the nucleus.   
In BEAS-2B cells treated with TiO2 nanoparticles in KF, the cell population displayed 
a concentration-dependent increase in side scatter (Figure 5B), with a ratio normalized to a 
control of 22.4 at 100 μg/ml (Appendix II, Table 4).  However, BEAS-2B cells treated with 
KB and DM showed lower side-scatter values at all concentrations compared to the KF 
medium, with DM < KB (Figure 5B).  The side-scatter ratios normalized to control for KB 
and DM were 12.2 and 10.6 at 100 μg/ml, respectively (Appendix II, Table 1).  This 
indicates less cellular interaction of TiO2 nanoparticles dispersed in KB and DM occurs 
compared with TiO2 nanoparticles dispersed in KF.   
2.4.3 Cytotoxicity of TiO2 nanoparticles  
The viability of BEAS-2B cells treated with TiO2 nanoparticles in all three treatment 
media was assessed by Live/Dead® staining and microscopy (Appendix II, Figure 7A) using 
a propidium iodide/calcein AM commercial kit (Invitrogen).  A 24-h exposure to TiO2 in all 
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three treatment media produced a <10% decrease in cell viability at the highest concentration 
(100 µg/ml).  This result was confirmed by the trypan dye-exclusion assay (Appendix II, 
Figure 8).  A 24-h exposure to 100-µM methyl methanesulfonate (MMS), which was used as 
a positive cytotoxicity control, confirmed the sensitivity of the Live/Dead® assay, with a 
mean cytotoxicity of 56% compared with untreated cells (data not shown).        
2.4.4 Genotoxicity 
We quantified DNA damage by the comet assay in BEAS-2B cells treated with TiO2 
nanoparticles as shown in Figure 6 and Appendix II Table 2.  There was a concentration-
dependent increase in DNA damage after TiO2 nanoparticle exposure in all three treatment 
media that was a weakly genotoxic but statistically significant.  However, there were no 
differences in the slopes of the concentration-response curves of the TiO2-induced DNA 
damage in the cells in the three media.  The 100-µM MMS (1-h exposure) positive control, 
run concurrently with each experiment and also shown in Figure 4, elicited a highly 
significant increase in induced DNA damage in all three treatment media. 
Chromosome breakage and loss were assessed by the cytokinesis-blocked MN assay 
as shown in Figure 7.  No increases in MN formation could be shown for BEAS-2B cells 
treated with any concentration of TiO2 nanoparticles in KB or DM.  However, TiO2 exposure 
in KF caused a significant concentration-related increase in MN.  The positive control, 100-
µM MMS, clearly induced a significant increase in MN in all three treatment media.    
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2.4.5 Cell Cycle 
To determine the effect of TiO2 nanoparticles in the three treatment media on cell 
cycle, treated BEAS-2B cells were lysed with non-ionic detergent (NP 40), incubated for 15 
min at 37oC, and stained with propidium iodide (PI) as described (Zucker et al., 1992).  The 
cells were put on ice prior to measuring them in a flow cytometer.   As shown in Figure 8, 
KB- and DM-treated cell populations exposed to different doses of TiO2 nanoparticles had 
cell-cycle profiles similar to those of untreated control cells.  However, TiO2 nanoparticle-
treated BEAS-2B cells in KF showed a significant concentration-dependent increase in the 
number of S-phase cells (Appendix II Table 3).  Other studies on the effects of TiO2 
nanoparticles on cell-cycle progression have found cell-cycle arrest in the short and long 
term (Huang et al., 2009; Wu et al., 2010).    
2.5 DISCUSSION 
	  
We evaluated the cytotoxicity, genotoxicity, agglomeration, cellular interaction, and 
effects on cell cycle of TiO2 nanoparticles prepared in three media:  (a) KB, which had a low 
concentration of protein (0.1% BSA); (b) DM, which had a lower level of protein (0.6% 
BSA) plus 0.001% surfactant; and (c) KF, which contained 10% FBS.  By measuring various 
physicochemical characteristics, we have attempted to determine which media influenced the 
genotoxicity of TiO2 nanoparticles based on two standard in vitro assays: the comet and the 
MN assays.     
Collectively, the sizing results demonstrate the increasing stability of dispersions with 
increasing amounts of protein as evidenced by the maintenance of agglomerate size during a 
24-h treatment period at concentrations from 10 to 100 µg/ml.  The rank order of 
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agglomeration size in treatment media based on the DLS data at 0 h and 24 h was KB > DM 
> KF.  Representative graphs of dynamic light scattering data show that TiO2 agglomeration 
increased with increasing concentration in each medium (Supplemental Figures 3-5).  The 
hydrodynamic diameter of TiO2 nanoparticles suspended in distilled water ranged from 273 
to 309 nm, consistent with previous studies (Table 2) (Ji et al., 2010).          
The size, PdI, and zeta potential of nanoparticles in solution can be influenced by 
characteristics of the medium such as protein concentration, pH, and type of nanoparticle (Ji 
et al., 2010).  In our study we confirmed this by showing an inverse correlation between 
protein concentration and average hydrodynamic diameter of TiO2 agglomerates in medium 
with the same temperature and pH and similar zeta potentials.  Additionally, we have shown 
that the protein corona on the nanoparticle surface as determined by SDS-PAGE is associated 
with the amount of protein in the treatment media (Appendix II, Figure 6).  These data 
indicate that the protein in the medium can adsorb to the nanoparticle surface and play an 
important role in surface presentation and agglomeration (Nel et al., 2009).  The ability of 
metal oxide nanoparticles to adsorb proteins onto their surface has been studied previously 
(Deng et al., 2009, Horie et al., 2009); however, the biological effects of this are not well 
understood.   
Our DLS data indicate that agglomeration size may play a primary role in cellular 
interaction of TiO2 nanoparticles, and the medium composition influences both 
agglomeration size and, consequently, nanoparticle uptake.  TiO2 nanoparticle-uptake has 
been associated with clathrin-coated endocytosis, caveolin-mediated endocytosis, and 
macropinocytosis (Thurn et al., 2011).  A study by Tedja et al. (2012) showed that FBS 
treatment of TiO2 nanoparticles similar to those used in our study increased cellular uptake 
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compared to the absence of FBS due to a second phase of uptake between 6-24 h.  
Furthermore, they showed that the cellular uptake of FBS-treated TiO2 nanoparticles 
occurred by clathrin-mediated endocytosis and that incubation with anti-vitronectin antibody 
reduced the cellular uptake of FBS-treated to the level of non-FBS treated TiO2 nanoparticles 
in A549 cells.  In our study we confirm the cellular uptake results shown by Tedja et al. in 
BEAS-2B cells and additionally show that medium mimicking BAL containing BSA and a 
surfactant can further reduce cellular uptake.  This result may mimic a real-world inhalation 
exposure more than standard in vitro studies due to nanoparticle-protein interactions with 
BAL, particularly lipids (Porter et al., 2008).  
Cytotoxicity is a primary biological endpoint in determining the toxicity of an 
environmental contaminant.  In this study we found that TiO2 nanoparticles were not 
cytotoxic at any concentration up to 100 µg/ml.  This result is in agreement with some 
reports (Bhattacharya et al., 2009; Falck et al., 2009) and in disagreement with others (Wang 
et al., 2007; Kang et al., 2008) on the cytotoxicity of TiO2 nanoparticles (Iavicoli et al., 
2011).  The differences in the literature may be due to the specific mechanism by which 
certain cytotoxicity assays evaluate cell changes, such as membrane permeability 
(Live/Dead® and trypan blue assays) versus mitochondrial function (3-(4,5-dimethylthiazole-
2-yl)-2,5-biphenyl tetrazolium bromide or MTT assay).  Some nanoparticles have been 
shown to cause disruption of the mitochondrial respiratory chain (Doak et al., 2009).  Several 
studies have shown the ability of nanoparticles to confound cytotoxicity results by interacting 
with and/or quenching colorimetric assays, fluorometric dyes, or reaction products in assays 
such as MTT, neutral red, monosodium salt (WST-1), and Coomassie blue (Hurt et al., 2006; 
Monteiro-Riviere et al., 2006; Worle-Nirsch et al., 2006; Belyanskaya et al., 2007; Casey et 
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al., 2007; Davoren et al., 2007; Doak et al., 2009).  Similar to previous studies from our 
group, we analyzed several images in each replicate experiment to ensure that TiO2 
nanoparticles in each treatment medium did not quench the specific dyes used (Appendix II, 
Figure 7B) (Sanders et al., 2012).    
Other genotoxicity studies have suggested that the DNA damage induced by TiO2 
nanoparticles detected by the comet assay likely occurs via oxidative stress due to hydroxyl 
radical formation.  TiO2 nanoparticles have been shown to produce ROS in vitro	  (Reeves et 
al., 2008; Jaeger et al., 2012) and by our group as measured by immuno-spin trapping in a 
cell-free system (Kitchin et al., 2011).  Furthermore, studies have used modified versions of 
the comet assay such as formamidopyrimidine DNA-glycosylase treatment to show oxidative 
stress-induced DNA damage by TiO2 nanoparticles (Gurr et al., 2005).  Proteomic studies 
performed by our group on BEAS-2B cells treated with TiO2 nanoparticles in KB show an 
increase in expression and activity of two of the most common anti-oxidant enzymes, 
catalase and superoxide dismutase.  Further, peroxiredoxins and actin proteins known to be 
associated with the Nrf-2-mediated anti-oxidative stress pathway were up-regulated as 
measured by 2D-gel electrophoresis analysis (Ge et al., 2011).  Based on our data and the 
aforementioned studies, we propose that the DNA damage measured by the comet assay may 
result from ROS.   
The use of serum for in vitro nanoparticle studies has been found to influence 
biological endpoints and has produced different responses with different types of 
nanoparticles (Maynard et al., 2006; Nel et al., 2006; Doak et al., 2009; Tedja et al., 2012). 
When comparing our study to the body of literature on the in vitro genotoxicity of TiO2 
nanoparticles, the majority of studies that gave positive results for the MN assay were in cell 
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lines in medium containing 10% or greater FBS in culture and during treatment (Rahman et 
al., 2002; Gurr et al., 2005; Wang et al., 2007); however, those that gave negative results 
were performed in serum-free medium (Falck et al, 2009). 
Rahman et al. (2002) have shown that TiO2 nanoparticles are clastogenic; thus, the 
MN seen in our study was due most likely to chromosome breakage.   If we assume the MN 
results are from chromosome breakage and not chromosome loss (aneuploidy), this effect 
would be dependent on the time of occurrence of the DNA damage in the cell cycle, the type 
of damage, whether the damage is repaired or not, and the passage of the cells through the 
cell cycle to the completion of nuclear division.    
We hypothesize that the effects seen in TiO2-treated cells in KF are due to 
nanoparticle-protein interactions that produce small agglomerates, which could be taken into 
the cell in greater amounts than larger agglomerates.  TiO2 nanoparticles in the cell may 
induce DNA damage regardless of media composition; however, the agglomerates formed in 
KF are more likely than agglomerates formed in the other media to induce a type of DNA 
damage that is processed into MN.  In contrast, TiO2 nanoparticles in KB and DM produced 
large TiO2 nanoparticle agglomerates that were not taken up as readily into the cell, and 
although DNA damage (comet) was induced by such agglomerates, these agglomerates were 
clearly unable to induce MN.   
DM, which contained a surfactant to mimic bronchial-alveolar fluid, served as a 
model for human inhalation exposure, whereas KF contained serum proteins that may mimic 
blood.  Our results showed that TiO2 nanoparticles induced a higher frequency of MN in KF 
than in DM, suggesting that TiO2 might be more genotoxic via ingestion than inhalation.  
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Indeed, such results have been found in vivo in mice where 5 days of ingestion of TiO2 
nanoparticles in drinking water induced clastogenicity, genotoxicity, oxidative damage, and 
inflammation (Trouiller et al., 2009), but 5 days of inhalation exposure induced only 
inflammation but no genotoxicity (Lindberg et al., 2012). The in vitro model used in our 
study is consistent with in vivo findings and clearly shows that there may be health effects 
associated with nano-scale versus micron-scale agglomerates of the same type of 
nanoparticle (NIOSH 2011).  This finding is important because real-world exposures are to a 
wide range of agglomerated nanoparticles.  A question moving forward in this field is to 
identify the size of agglomerates that can lead to adverse outcomes.  These studies and our 
data suggest that route of exposure may play a critical role in the potential genotoxicity of 
TiO2 nanoparticles to humans.          
A limitation of this study is the various ways in which the nanoparticles were 
prepared.  We note that the preparation procedures involved in the dispersal and sonication of 
TiO2 nanoparticles in each treatment medium differ.  Also, the addition of serum could 
potentially act to differentiate the BEAS-2B cells.  However, we derive our conclusions from 
cytotoxicity, cell-cycle populations in the untreated controls, and the cytokinesis-blocked 
proliferation index (CBPI) data (Appendix II Figures 6 and 7, Figure 5B and 6) that show no 
significant differences among the treatment media at all concentrations tested.  In addition, 
comparison of the negative and positive controls across all assays showed no effect of 
treatment medium.  Additional studies are needed on the ability of nanoparticles to bind to 
extracellular and intracellular proteins, the mechanism of cellular interaction/uptake, and 
subsequent mechanisms of toxicity. 
50 
	  
As summarized in Table 3, we have identified the physicochemical characteristics of 
TiO2 nanoparticles, their cellular uptake, and their ability to induce genotoxicity and alter the 
cell cycle in three treatment media of various compositions, defined by protein and lipid 
concentration.  The results showed that the particles agglomerated less in particle-treatment 
medium that contained 10% FBS (KF) compared to medium with less protein (KB) or 
medium composed of less protein + surfactant (DM).  We find that the smaller TiO2 
nanoparticle agglomerates in the KF medium are more associated with cellular interaction 
than in the other two media (that formed larger agglomerates).  This result is likely due to the 
protein corona formed in KF relative to the other two media.  The DNA damage as measured 
by the comet assay was induced equally by the nanoparticles in all three media, indicating 
that the hydrodynamic diameter of the agglomerates had no influence on the ability of the 
nanoparticles to induce DNA damage as measured by the comet assay. In contrast, the 
consequence of the differential agglomeration and particle interaction among the media is 
that the chromosomal damage as measured by the MN assay and the increased percentage of 
S-phase cells occur only in the KF medium, due to the protein in this medium relative to the 
other two media.          
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Chapter 3       
TITANIUM DIOXIDE NANOPARTICLES ACTIVATE THE ATM-CHK2 DNA 
DAMAGE RESPONSE IN HUMAN DERMAL FIBROBLASTS 
 
3.1 OVERVIEW 
	  
 The use of nanoparticles in consumer products increases their prevalence in the 
environment and the potential risk to human health. Although recent studies have shown in 
vivo and in vitro toxicity of titanium dioxide nanoparticles (nano-TiO2), a more detailed view 
of the underlying mechanisms of this response needs to be established. Here the effects of 
nano-TiO2 on the DNA damage response and DNA replication dynamics were investigated 
in human dermal fibroblasts. Specifically, the relationship between nano-TiO2 and the DNA 
damage response pathways regulated by ATM/Chk2 and ATR/Chk1 were examined. The 
results show increased phosphorylation of H2AX, ATM, and Chk2 after exposure. In 
addition, nano-TiO2 inhibited the overall rate of DNA synthesis and frequency of replicon 
initiation events in DNA combed fibers. Taken together, these results demonstrate that 
exposure to nano-TiO2 activates the ATM-Chk2 DNA damage response pathway. 
3.2 INTRODUCTION 
	  
Titanium dioxide nanoparticles (nano-TiO2) are used in sunscreens, paints, and 
cosmetics because of their high refractive index and absorptive qualities (Baan et al. 2006).  
The major consumer usage of nano-TiO2 is in sunscreens which presents a highly probable 
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dermal exposure.  Studies have shown that nano-TiO2 can cause pregnancy complications as 
well as DNA damage when consumed in water in mice (Trouiller et al. 2009; Yamashita et 
al. 2011).  In addition, the genotoxicity of nano-TiO2 has also been demonstrated in vitro at a 
variety of concentrations in several cell lines.  Specifically, DNA damage and chromosome 
damage have been shown in human lung epithelial cells (Gurr et al. 2005), lymphoblastoid 
cells (Wang et al. 2007), Syrian hamster embryo fibroblasts (Rahman et al. 2002), peripheral 
blood lymphocytes (Kang et al. 2008) and a human fetal hepatic cell line (Shi et al. 2010).  
However, other studies reported negative results in these same endpoints (Theogaraj et al. 
2007; Falck et al. 2009; Hackenberg et al. 2011).  Despite the literature on the toxicity of 
nano-TiO2, very few studies have investigated these effects at concentrations lower than 10 
µg/ml.  The investigation of cellular response to DNA damage is paramount to understanding 
the potential carcinogenicity of a toxicant. 
The data on real world nano-TiO2 exposures in the environment are limited; however, 
studies have used various models and assumptions in order to estimate environmental 
concentrations.  The U.S. Food and Drug Administration (FDA) has set a maximum 
concentration of titanium dioxide (by weight) at 25% without distinguishing between particle 
size (U.S. FDA 1999).   The U.S. Environmental Protection Agency’s (EPA) case study on 
nano-TiO2 lists the average conventional usage of titanium dioxide in sunscreen at 2 to 15%.  
The EPA case study also estimates that the amount of nano-TiO2 applied on skin as part of 
sunscreen for an adult outdoors for four hours is in the range of 1.0 to 4.6 g/person (or 8.0-37 
mg/kg body weight) and 0.33 to 1.5 g/person (or 12-55 mg/kg body weight) for a 3-year-old 
infant (U.S. EPA, 2009).  Additionally, it has been reported that the average consumer uses 
0.5-1.5 mg of sunscreen/cm2 skin (Srinivas et al. 2006).  Assuming the average amount of 
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nano-TiO2 in sunscreen is ~5% w/w, the average skin exposure could be in the range of 25-
75 μg nano-TiO2/cm2.    
The cellular response to DNA damage relies on a variety of cell cycle checkpoints 
and DNA repair pathways (Ciccia and Elledge, 2010).  S phase cells are the most vulnerable 
to mutations associated with DNA damage, thereby making the intra-S checkpoint important 
in avoiding mutagenic events associated with replicating damaged DNA.  The intra-S 
checkpoint signaling pathways are used to slow replication and repair damaged DNA in 
order to minimize mutations and chromosome aberrations.  Immunofluorescence microscopy 
of DNA combed fibers is an accepted method used to measure replication fork stalling and 
origin initiation (Merrick et al. 2004).  This information, combined with an analysis of the 
major intra-S checkpoint signaling kinases ATM-Chk2 and ATR-Chk1, can provide insight 
into the cellular response to DNA damaging agents.  To date, the cellular response to 
nanoparticle-induced DNA damage and downstream checkpoint signaling mediated through 
ataxia telengiectasia-mutated (ATM) or ATM and Rad3-related (ATR) has not been 
investigated. 
Two well-studied carcinogens, ultraviolet light (UV) and ionizing radiation (IR), have 
become the models for determining the intra-S checkpoint signaling response to DNA 
damage (Chastain et al. 2006).  Ultraviolet light has been shown to increase the risk of cancer 
through the generation of DNA photoproducts that block DNA polymerases, the arrest of 
replication forks, and upregulation of ATR-Chk1 dependent DNA repair (Kaufmann 2010).  
Ionizing radiation causes DNA double strand breaks, with the cellular response occurring via 
upregulation of ATM-Chk2-dependent DNA repair (Bartek et al. 2004).  If DNA damage 
caused by exposure to nano-TiO2 acts primarily via the ATM-Chk2 pathway, then cells 
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would respond to nano-TiO2 through a pathway similar to IR.  Alternatively, if exposure to 
nano-TiO2 acts primarily via the ATR-Chk1 pathway, then nano-TiO2 would act through a 
pathway similar to UV.  IR and UV are known carcinogens, whereas, titanium dioxide is 
currently classified by IARC as a group 2B carcinogen or “possibly carcinogenic to humans” 
(IARC Monograph #93, 2010).   
In this study, low, non-cytotoxic concentrations of nano-TiO2 were tested in cultures 
of human dermal fibroblasts.  Activation of the DNA damage response was monitored by 
quantification of the phosphorylation of H2AX, ATM, and Chk2 by immunocytochemistry, 
quantification of DNA replication dynamics using immunofluorescence microscopy of 
combed DNA fibers, and quantification of intra-S checkpoint signaling by western blot 
analysis of phosphorylation of ATM and Chk1.  Using the well-established models of UV 
and IR as a guide, the DNA damage response, DNA replication dynamics, and intra-S 
checkpoint signaling upon exposure to nano-TiO2 were determined.    
3.3 MATERIALS AND METHODS 
	  
3.3.1 Cell lines and culture conditions  
Human dermal fibroblasts were isolated from two independent neonatal foreskins by 
Dr. Jayne Boyer.  Briefly, foreskins were incubated in dispase II overnight at 4 ºC.  The 
epidermis and dermis were then separated.  The dermis was cut and incubated in collagenase 
overnight at room temperature and inactivated with media and serum.  Fibroblasts were 
centrifuged and the cell pellet was cultured.  Logarithmically growing cultures were 
maintained and treated from passage 3-10 in Dulbecco’s modified eagle medium (Mediatech, 
Inc., Manassas, VA) supplemented with 10% fetal bovine serum (Invitrogen) and 1% 
55 
	  
Penicillin-Streptomycin (Thermo Scientific) at 37 ºC in a humidified incubator at 5% CO2.  
At 85-90% confluence, cells were trypsinized with 0.25% Trypsin-EDTA (Thermo 
Scientific) and reseeded at a density of 2.5 x 104 cells/cm2.  Cells were counted using a Vi-
Cell XR coulter counter (Beckman Coulter). 
 
3.3.2 Nanoparticle treatment conditions   
Titanium dioxide nanoparticles (15 nm and 100% anatase crystal structure, as 
reported by the manufacturer) were purchased from Nanostructed and Amorphous Materials 
(NanoAmor, Houston, TX).  10-20 mg of titanium dioxide nanoparticles were weighed on 
the day of the experiment and suspended in the cell culture medium at a concentration of 1 
mg/ml.  The dispersion was sonicated using a micro-tip probe sonicator (Cole Parmer) for 2 
minutes at 40% amplitude setting as recommended by the manufacturer. Sonication has been 
used previously in the literature to disperse nano-TiO2 (Hackenberg et al. 2010).  Cells were 
treated for 24 h at a final concentration of 100, 30, 10, 3, and 1 µg/ml (20 - 0.285 μg/cm2).  
This preparation method was used to mimic potential dermal exposure to nano-TiO2 from 
sunscreens that may contain up to 75-µg nano-TiO2/cm2 under current regulations.  
Furthermore, it has been hypothesized that the rubbing-in of sunscreen formulations with 
nano-TiO2 agglomerates may act to disperse these agglomerates (McCall, 2011).        
 
3.3.3 Scanning Electron Microscopy  
Particle dispersions were prepared, as described earlier, at concentrations of 1 mg/ml 
and a drop was placed on a glass slide. The drop was allowed to dry, and the glass slide was 
coated with 1.5 nm of Au/Pd alloy using a Cressington 108 auto sputter coater (Cressington 
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Scientific Instruments). The Au/Pd-coated glass slide was then adhered to the sample holder 
and placed inside the vacuum chamber of the SEM and observed under high vacuum.  
 
3.3.4 Transmission Electron Microscopy  
  Transmission electron microscopy (TEM) was carried out to further visualize the 
intracellular internalization and localization of nano-TiO2. Approximately 5 × 105 human 
dermal fibroblasts were seeded in a six well plate overnight. The following day, cells were 
treated with nano-TiO2 as described above.  Briefly, cell monolayers were rinsed with 
Dulbecco’s phosphate buffered saline and fixed in 2% paraformaldehyde/2.5% 
glutaraldehyde/0.15M sodium phosphate at pH 7.4, for several hours or overnight.  After 
rinsing with sodium phosphate buffer, the monolayers were fixed for 1 h in 1% osmium 
tetroxide/1.25% potassium ferrocyanide/0.15M sodium phosphate buffer. After rinsing in 
deionized water, the cells were dehydrated by going through a graded series of ethanol and 
embedded in Polybed 812 epoxy resin (Polysciences).  The monolayers were sectioned 
parallel and perpendicular to the substrate at 90-100 nm using a diamond knife.  Ultrathin 
sections were collected on 200-mesh copper grids and viewed using a JEOL JEM 100CXII 
(Jeol America Inc, Peabody, MA) transmission electron microscope located at the CHANL 
core facility (Chapel Hill, NC).  Digital images were acquired using a Gatan Orius SC1000 
CCD Digital Camera and Digital Micrograph 3.11.0 (Gatan, Inc.). 
 
3.3.5 Dynamic Light Scattering Measurements 
Nano-TiO2 at 1, 3, 10, 30 and 100 µg/ml in Dulbecco’s modified eagle medium 
(Mediatech, Inc., Manassas, VA) supplemented with 10% fetal bovine serum and 1% 
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penicillin-streptomycin were analyzed for size and zeta potential with a ZetaSizer Nano 
(Malvern Instruments).  Settings involved a refractive index of 2.61 reflecting the titanium 
dioxide anatase crystal structure.  To ensure the quality assurance of the measurements, each 
correlation function graph was analyzed to ensure a y-intercept ≤1.0.  Distribution algorithm 
results were used in order to ensure that multiple peaks could be recorded if necessary.  Each 
measurement was performed in triplicate, and results are the mean ± SD of three independent 
experiments. 
 
3.3.6 Cytotoxicity  
Fibroblasts treated for 24 hr with nano-TiO2 were trypsinized as mentioned above.  A 
cell suspension of 600 µl was placed into a ViCell XR coulter counter with specifications for 
measuring fibroblasts with nanoparticles.  Fifty images of ~15-20 stained cells/image were 
stored and analyzed using ViCell 2.03 analysis software (Beckman Coulter).  Cells with blue 
nuclei were scored as dye-positive.  Images were saved and re-analyzed to ensure there was 
no confounding influence of the nanoparticles on the results.  The results are expressed as the 
mean ± SD of four independent experiments. 
 
3.3.7 Immunocytochemistry analysis of pH2AX, pATM, and pChk2  
  Mouse monoclonal anti-phospho-ser139-H2AX (pH2AX) was purchased from 
Millipore (Billerica, MA), rabbit monoclonal anti-phospho-ser1981-ATM (pATM) was 
purchased from Epitomics (Burlingame, CA), and rabbit monoclonal anti-phospho-thr68-
Chk2 (pChk2) was purchased from Cell Signaling Technology (Danvers, MA).  Cells were 
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seeded in six wells of an eight well chamber slide at a density of 2.5 x 104 cells/chamber.  
This allowed the examination of multiple concentrations of nano-TiO2 on the same scaffold.  
After 24 hours to allow adherence to the slide, cells were treated with nano-TiO2 for 24 hr.  
Cells in chamber slides were fixed in 10% formalin for ten minutes and washed with 
phosphate buffered saline. Immunocytochemistry was carried out in the Bond Autostainer 
(Leica Microsystems Inc.  Norwell, MA 02061).  Antigen retrieval was performed for 30 min 
at 100ºC in Bond-Epitope Retrieval solution 1 pH-6.0 (AR9961).  Slides were incubated with 
primary antibody for eight hours followed by antibody detection with the Bond Polymer 
Refine Detection System (DS9800).  Stained slides were dehydrated and cover-slipped.  
Positive and negative controls (no primary antibody) were included for each run.  The results 
are the mean ± SD of three independent experiments. 
Stained chamber slides were digitally imaged using the Aperio ScanScope XT 
(Aperio Technologies, Vista, CA).  Digital images were stored and analyzed within the 
Aperio Spectrum Database.  TMALabTM (Aperio) software was used to segment each 
compartment of the chamber slide as an individual sector comprised of the 12 individual 
spots, representing randomly selected areas.  The expression of the antibodies was measured 
using the Aperio Nuclear V9 (cell quantification) algorithm.  Algorithm parameters, 
including curvature threshold and min nuclear size, were tuned to achieve the optimal cell 
segmentation.  The results were scored and are reported as % positive nuclei.  Additionally, 
total nuclei scored/chamber were counted to determine differences in cell growth.  
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3.3.8 Immunofluorescence microscopy of combed DNA fibers 
This protocol was performed as previously described (Chastain et al. 2006).  Briefly, 
fibroblasts were first incubated with 10-µM iododeoxyuridine (IdU) for 10 min and after 
treatment with nano-TiO2 at various concentrations for 1 hour, with 100 µM 
chlorodeoxyuridine (CldU) for 20 min.  DNA spreads were made as described previously 
(Jackson and Pombo, 1998).   The cells were trypsinized and resuspended in ice-cold PBS at 
~200 cells/µl.  To create the DNA combed fibers, 2 µl of cell suspension were mixed with 
7.5 µl spreading buffer [0.5% SDS in 200 mM Tris-HCl (pH=7.4), 50 mM EDTA] on a glass 
slide.  After 10 min, the slides were tilted at ~15º to allow the cell lysates to slowly move 
down the slide, resulting in DNA spreads.   The slides were air-dried, fixed in 3:1 
methanol/acetic acid for 2 min, and refrigerated overnight.  DNA combed fibers were stained 
and analyzed for relative DNA synthesis and new DNA origins as previously described 
(Chastain et al. 2006).  Relative DNA synthesis (or replicon initiation) was measured by the 
length of green segments in red/green tracks whereas relative origin firing was measured by 
the number of green only tracks (Wang et al. 2011).   Results are normalized to the untreated 
control and expressed as mean ± SD of three independent experiments. 
 
3.3.9 Western blotting 
 Antibodies specific for phospho-Ser 345 Chk1 (Cell Signaling Technology, Danvers, 
MA), Chk1 (Santa Cruz Biotechnology, Santa Cruz, CA), phospho-Ser1981 ATM 
(Epitomics, Burlingame, CA), ATM (Bethyl Laboratories, Montgomery, TX), phospho-
Ser139 H2AX and H2AX (Millipore, Billerica, MA) were obtained.  Cells were trypsinized 
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24 hours after treatment with nano-TiO2 and counted using a Vi-Cell Coulter Counter 
(Beckman Coulter).  Protein quantification was performed using the Coumassie Plus™ 
Protein Assay (Thermo Scientific) and NanoDrop 2000c spectrophotometer (Thermo 
Scientific).  Preparation of whole cell extracts was done by heating cells in gel-loading buffer 
to 100 ºC for 10 min (Bower et al. 2010).  Equal amounts of protein were run on an 8-16% 
Precise™ protein gel (Thermo Scientific) at 120V for 1 hour at room temperature in a 
vertical electrophoresis system (Fisher Biotech).  The polyacrylamide gel was transferred to a 
Hybond-P PVDF membrane (GE Healthcare) in a mini-tank electroblotter (Fisher Biotech) at 
400 mA for 2 hr at 4ºC.  Primary antibody dilutions were all performed at 1:1000 in tris-
buffered saline supplemented with 0.1% tween 20 with 5% non-fat dried milk for non-
phosphorylated antibodies and tris buffered saline supplemented with  0.1% tween 20 with 
5% BSA for phosphorylated antibodies.  Secondary dilutions with anti-rabbit IgG HRP-
linked or anti-mouse IgG HRP-linked antibodies (Cell Signaling Technology, Danvers, MA) 
were all performed at 1:2000 dilution in tris-buffered saline supplemented with 0.1% tween 
20 with 5% non-fat dried milk.  Enhanced chemiluminescence using ECL Plus reagent (GE 
Healthcare) and X-ray film exposure was performed as previously described (Kaufmann et 
al. 2003, Heffernan et al. 2002).  Membranes were washed appropriately with tris-buffered 
saline supplemented with 0.1% tween 20 before and after primary and secondary antibody 
treatment.  Blots were scanned and analyzed using ImageJ software (NIH). The results are 
the mean ± SD of three independent experiments.   
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3.3.10 Statistical Analysis 
The data are presented as mean ± SD. All immunocytochemistry, replication fork 
stress, origin firing, and western blot results were tested for significance using two-tailed t-
tests comparing each concentration and positive control to the untreated control.  The p value 
was set at 0.05 to determine significance. All data was analyzed using GraphPad Prism 5 
statistical analysis software. 
 
3.4 RESULTS 
	  
3.4.1 Nano-TiO2 form agglomerates in cell culture medium 
Physical characterization of nanoparticles in both dry form and dispersion has 
become paramount to the field of nanotoxicology (Warheit 2008, Sayes and Warheit 2009).    
Titanium dioxide anatase nanoparticles of 15 nm and 99.7% purity were used in this study.  
Analysis by scanning electron microscopy showed dry particle agglomerates (Figure 9).  
Additionally, transmission electron microscopy was performed on human dermal fibroblasts 
after 24 hr exposure (Appendix III, Supplemental Figure 10).  Nano-TiO2 agglomerates were 
internalized and primarily located in the cytoplasm of the fibroblasts, which is consistent 
with previously published work (Andersson et al. 2011).  Dynamic light scattering was 
performed to determine the size of nano-TiO2 in cell culture media (DMEM supplemented 
with 10% FBS and 1% Pen-Strep) (Table 4).  The nanoparticle suspension showed 
significant agglomeration from the manufacturer’s size, increasing in correlation to the mass 
concentration. 
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3.4.2 Concentration dependent nano-TiO2 exposure decreases viability of human dermal 
fibroblasts 
	  
 Assessment of cell viability was performed using the trypan dye exclusion assay.  As 
shown in Figure 10, there was a concentration-dependent decrease in cell viability in human 
dermal fibroblasts treated with nano-TiO2.  Nano-TiO2 was significantly cytotoxic at 30 and 
100 μg/ml in human dermal fibroblasts after 24 h exposure (cell viability: 30 μg/ml = 58.4% 
± 10.3%; 100 μg/ml = 41.2% ± 0.5%).  This method was selected to enable a comparison of 
our results with other published studies in the literature that also found decreased cell 
viability at higher concentrations of nano-TiO2 (Lewinski et al. 2008, Arora et al. 2012). 
 
3.4.3 Nano-TiO2 exposure is associated with phosphorylation of H2AX, ATM, and Chk2 as 
determined by immunocytochemistry  
	  
Immunocytochemical staining and analysis of phosphorylated histone 2AX (pH2AX) 
can be used as a marker of DNA double strand breaks (Kinner at al. 2008), but is also 
indicative of replication stress.  As shown in Figure 11A, nano-TiO2 produced a statistically 
significant increase of pH2AX as determined by % positive nuclei after 24 hr exposure at 1 
and 3 μg/ml (0 μg/ml = 5.3% ± 5.13%; 1 μg/ml = 54.3% ± 12.7%; 3 μg/ml = 53% ± 8.19%).  
In Figure 11B, pATM showed a statistically significant increase in % positive nuclei after 24 
hr exposure at 3 μg/ml (0 μg/ml = 29% ± 9.3%; 3 μg/ml = 55% ± 15.27%).  In Figure 3C, 
pChk2 showed a statistically significant increase in % positive nuclei after 24 hr exposure at 
1 and 3	  μg/ml (0 μg/ml = 1% ± 0.82%; 1 μg/ml = 5% ± 0.82%; 3 μg/ml = 10.25% ± 1.26%).  
63 
	  
There were no differences in total nuclei scored/chamber between treated and untreated cells 
(Appendix III, Supplemental Table 4).         
 
3.4.4 Nano-TiO2 exposure decreases relative DNA synthesis and origin firing in human 
dermal fibroblasts 
	  
With two fluorescent probes used pre and post exposure to nano-TiO2 respectively, 
we monitored the rates of DNA synthesis in active replicons and replicon initiation.  This 
fiber-labeling technique has been used previously in UVC-irradiated mammalian cells 
(Chastain et al. 2006) as well as Saccharomyces cerevisiae treated with methyl methane 
sulfonate (MMS) and hydroxyurea (Tercero and Diffley, 2001, Shirahige et al. 1998).  As 
shown in Figure 12A, a concentration-dependent decrease in DNA synthesis was found that 
reached statistical significance (relative to the untreated control) at 10, 30 and 100 μg/ml.  In 
Figure 12B, relative origin firing (as a measure of replicon initation) also displayed a 
concentration-dependent decrease, displaying significance from the untreated control at 10, 
30 and 100 μg/ml.  
 
3.4.5 Human dermal fibroblasts respond to nano-TiO2 exposure with activation of 
ATM/Chk2 DNA damage response pathway  
	  
Following the results from the immunocytochemistry analysis, we set out to examine 
DNA repair pathways modulated by ATM/Chk2 and ATR/Chk1 kinases in response to nano-
TiO2.  To investigate these pathways, western blotting was used to determine the 
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phosphorylation of serine residues on ATM, Chk1, and H2AX proteins (Figure 13A).  Only 
three concentrations were tested because of the significantly reduced cell viability in the cells 
exposed to higher concentrations (30 and 100 μg/ml) of nano-TiO2.  Phosphorylation of 
ATM increased with increasing concentrations of nano-TiO2, and was significantly higher at 
3 and 10 µg/ml (Figure 13B).  Phosphorylation of H2AX was significantly higher at 1 and 10 
μg/ml, but not at 3 μg/ml (p = 0.51) (Figure 13C).  There was no phosphorylation of Chk1 at 
any concentration of nano-TiO2 even though the positive control (UV-treatment) generated a 
robust p-Chk1 signal.     
The phosphorylation of H2AX seen in immunocytochemistry was confirmed by 
western blotting with an elevated increase in pH2AX/H2AX ratio at 1, 3, and 10 μg/ml 
(Figure 5C).  It should be noted that the positive control, UV-C, was tested at a fluence that 
results in ~60% cell viability (5 J/m2).  At such a dose, UV-C induces pATR, pH2AX, and 
ATR-dependent ATM phosphorylation as previously described (Stiff et al. 2006).  As such, 
there exists cross-talk between the ATM and ATR pathways, where a sufficient UV-C dose 
can elicit ATR-dependent phosphorylation of ATM.  However, the primary driving event for 
cellular response to both IR and UV-C are ATM and ATR, respectively.  The increases 
shown in the Western blot reflect the increases seen in the immunocytochemical analysis 
shown in Figure 11.   
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3.5. DISCUSSION 
	  
This study aimed to identify whether nano-TiO2 induces: (i) DNA double strand 
breaks assessed by immunocytochemistry and western blot analysis of phosphorylation of 
H2AX, (ii) relative DNA synthesis and origin firing using immunofluorescence microscopy 
of combed DNA fibers, and (iii) intra-S checkpoint signaling by immunocytochemistry and 
western blot analysis of phosphorylation of ATM, Chk2 and Chk1 in human dermal 
fibroblasts.  Assessing the DNA damage response and replicon dynamics provides a critical 
view of the biological response to nano-TiO2 exposure.   
Potential exposure to nano-TiO2 can occur through several routes due to their 
presence in sunscreens, water and aerosols.  As a result, exposure can target various tissues 
such as the skin and the lung.  For exposure through water, a model was developed to 
estimate predicted environmental concentrations (PEC) and predicted no-effect 
concentrations (PNEC) of nano-TiO2.  The reported values of 0.7 µg/L for PEC and 16 µg/L 
of PNEC reflected a “realistic scenario” and a “high scenario” (Mueller and Nowack, 2008).  
For potential lung exposure, the U.S. National Institute for Occupational Safety and Health 
(NIOSH) has a draft bulletin for nano-TiO2 that recommends “0.1 mg/m3 as time weighted 
average concentrations for up to 10 hr/day during a 40 hr work week” (NIOSH 2005).  A 
study by the National Center for Computational Toxicology (NCCT) used these values to 
extrapolate for in vitro inhalation exposures and found that a range of 30-400 µg/ml was 
appropriate for nano-TiO2 exposure over a lifetime (Gangwal et al. 2011).  Despite these 
recommendations, no nanoparticle-specific recommendations have been made for consumer 
products.     
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 In this study, human dermal fibroblasts were exposed to non-cytotoxic 
concentrations of nano-TiO2 (e.g. 1, 3, and 10 µg/ml or 0.285, 0.857, and 2.85 μg/cm2).  The 
published literature on nano-TiO2 in mouse and human fibroblasts in vitro describes 
concentrations greater than or equal to those used here (Pan et al. 2009, Jin et al. 2008, 
Romoser et al. 2012).  Extrapolation of the EPA case study numbers gives a range of 25 – 75 
μg of nano-TiO2/cm2 skin.  Thus, the concentrations used in this study are lower than those 
estimated by the EPA case study for skin exposure.  In intact, healthy skin, nano-TiO2 has not 
been shown to penetrate past the stratum corneum (Sadrieh et al. 2010).  However, studies 
using UVB sunburned skin showed Ti within the epidermis and superficial dermis 
(Monteiro-Rivere et al. 2011).  Immunocompromised skin and skin with open wounds may 
present a potential susceptible phenotype by which human dermal fibroblasts can be exposed 
to nano-TiO2.   
DNA damage has been shown to occur at ≥10 μg nano-TiO2/ml exposure in most in 
vitro studies (Singh et al. 2009).  However, most genotoxicity studies with nanoparticles use 
the alkaline single cell gel (comet) and micronucleus assays to assess DNA damage and 
chromosome breakage, respectively.  It has been shown previously that phosphorylation of 
H2AX is not only a marker for double strand breaks, but it is also critical for recruitment of 
repair factors after DNA damage (Paull et al. 2000).  A recent study by Trouiller et al. found 
pH2AX to be the most sensitive marker of DNA damage in response to nano-TiO2 exposure 
(Trouiller et al. 2009).   This former study was performed in vivo with concentrations of 
nano-TiO2 ranging from 60-600 μg/ml in drinking water causing statistically significant 
increases in pH2AX in bone marrow.  The results from our study demonstrate increases in 
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pH2AX after 24 h exposure in human dermal fibroblasts in vitro using immunocytochemistry 
and western immunoblotting.   
Upon exposure to agents that damage DNA, cells can initiate a host of responses that 
include the reduction of the rate of synthesis in order to minimize the risk of developing 
mutations. Here we found reduced rates of DNA synthesis in active replicons and reduced 
origin firing after one hour incubation with concentrations at and above 10 µg/ml.  To our 
knowledge, this is the first study to look at replication dynamics in DNA combed fibers after 
exposure to nano-TiO2.  Such a reduced rate of synthesis after exposure may be the result of 
cell cycle checkpoint activation in response to DNA damage.  Similar to our results for nano-
TiO2, IR has been shown to inhibit DNA synthesis through ATM-Chk2 signaling (Painter 
and Young, 1980, Falck et al. 2001).  Other studies have shown a change in cell cycle 
progression as a result of nanoparticle exposure (Huang et al. 2009, Wu et al. 2010).  More 
studies are necessary to investigate the effects of nanoparticles on DNA replication and cell 
cycle dynamics. 
Cellular pathways that are altered in response to nanoparticle exposure have not been 
studied thoroughly.  It has been shown that the phosphorylation of p53 and p53-
transactivation targets such as p21 and Bax occur as a result of a high concentration (50 
µg/ml) of nano-TiO2 exposure in human peripheral blood lymphocytes (Kang et al. 2008).  
Here, we sought to determine whether the cellular response to DNA damage from lower 
concentrations of nano-TiO2 was through a mechanism similar to IR and/or UV exposure.  
IR-induced S-checkpoint signaling is dependent upon ATM recognizing DNA double strand 
breaks and initiating a cascade that inhibits replicon initiation and DNA synthesis in active 
replicons (Falck et al. 2001).  ATM phosphorylates Chk2 and pChk2 proceeds to 
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phosphorylate Cdc25A to induce ubiquitin-mediated proteolysis of Cdc25A, resulting in 
inhibition of DNA synthesis (Busino et al. 2003).  UV-induced S-checkpoint signaling is 
shown to be dependent upon ATR activation at replication forks that are stalled at UV-
induced DNA 6-4 photoproducts (Kaufmann 2010).  Once activated, ATR acts through Chk1 
to inhibit replicon initiation and induce S phase arrest (Heffernan et al. 2007).  While these 
paradigms largely hold true, in instances of high dose exposures to UV-C and IR, an ATR-
dependent phosphorylation of ATM and ATM-dependent phosphorylation of ATR can occur 
(Stiff et al. 2006).  In our study, the absence of a detectable signal of p-Chk1 in TiO2 
nanoparticle-treated cells suggests that ATR was not activated. 
From previous studies, nano-TiO2 has been shown to induce DNA lesions through 
reactive oxygen species (ROS) as assessed by the formamido-pyrimidine-DNA-glycosylase 
(Fpg) comet assay in vitro, which recognizes oxidatively damaged purines (Shukla et al. 
2011a, Shukla et al. 2011b). In addition, it has been shown that exposure to nano-TiO2 
induces DNA radicals using an immuno spin trapping technique (Kitchin et al. 2011).  ROS 
and radical induced DNA damage, if clustered, can yield DNA double strand breaks that can 
activate the ATM-Chk2 signaling pathway.  However, studies have also shown that some 
types of nano-TiO2 are weak producers of ROS (Moller et al. 2010).  More studies should be 
performed to specifically examine the types and amounts of ROS produced by exposure to 
nano-TiO2.     
The data shown here demonstrate that nano-TiO2 induces phosphorylation of H2AX, 
a marker of DNA damage.  Relating the findings of our study with known mechanisms 
established for standard responses to UV and IR, it can be seen that after 24 hr exposure, 
nano-TiO2 acts primarily through the phosphorylation of ATM/Chk2, in a manner similar to 
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IR.  In addition, we show that the ATR/Chk1 pathway is not activated in response to nano-
TiO2 exposure.  These results demonstrate that exposure to nano-TiO2 induces activation of 
the ATM/Chk2 DNA damage signaling pathway (Figure 14). 
This study examined the effects of nano-TiO2 on DNA damage response pathways 
including phosphorylation of H2AX, replicon dynamics, and intra-S checkpoint signaling.  
The results indicate that human dermal fibroblasts exposed to nano-TiO2 respond primarily 
via the ATM/Chk2 pathway.  Future research on the effects of nano-TiO2 on replication 
dynamics and DNA damage response are necessary if the impact on human health is to be 
fully understood 
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Chapter 4  
CELLULAR INTERACTION AND BIOLOGICAL RESPONSE TO TITANIUM DIOXIDE 
NANOPARTICLES IN HEPG2 AND BEAS-2B CELLS: ROLE OF CELL CULTURE 
MEDIA 
 
4.1 OVERVIEW 
	  
The combination of increased human exposure to engineered nanoparticles and the 
novel properties they possess creates the need for comprehensive risk assessment.  We have 
shown previously that the composition of the biological medium used in vitro can affect the 
cellular interaction and biological response of titanium dioxide nanoparticles (nano-TiO2) in 
human lung epithelial cells.  However, it is unclear if these effects are conserved in all cell 
types, particularly in the liver, where in vivo biodistribution studies have shown nanoparticle 
localization after exposure. In this study a systematic assessment of protein adsorption, 
agglomeration, cellular interaction, and a battery of cellular responses associated with DNA 
damage and inflammation were examined in human hepatoma (HepG2) cells to determine if 
the relationship between agglomeration, cellular interaction, and genotoxicity from our 
previous study is conserved in a different cell type.  Cells were exposed to nano-TiO2 for 24 
h in two treatment media: DB: Dulbecco’s modified eagle medium (DMEM) supplemented 
with 0.1% bovine serum albumin (BSA) and DF: DMEM supplemented with 10% fetal 
bovine serum (FBS).  We found that nano-TiO2 formed agglomerates (~200-400 nm) and 
induced DNA damage, micronuclei formation, phosphorylation of ataxia telangiectasia-
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mutated (ATM), and transcriptional activation of NF-κB similarly in both media.  In contrast 
we found in a previous study with different base and treatment medium, KGM supplemented 
with 0.1% BSA (KB), that nano-TiO2 formed larger agglomerates than observed here with 
DB, and showed reduced cellular interaction and micronuclei formation in BEAS-2B cells.  
In exploring this apparent discrepancy between studies, we examined KB and KB 
supplemented with glucose and potassium chloride (KB-Plus) at concentrations equal to that 
of DMEM for agglomeration as well as cellular interaction and micronuclei formation in 
BEAS-2B cells.  We found no significant differences between cells reared in KB versus KB-
Plus for any of the three endpoints.  Collectively, our data chronicle the genotoxicity and 
cellular response of HepG2 cells after nano-TiO2 exposure and suggest that cell type and cell 
culture conditions impact biological response.    
4.2 INTRODUCTION 
	  
Titanium dioxide nanoparticles (nano-TiO2) have been used as an additive to 
sunscreens, paints, toothpastes, and food coloring due to their small size, white pigmentation, 
resistance to degradation, and high refractive index (Weir et al., 2012).  In 2010 nano-TiO2 
production was reported at approximately 5000 tons with increased production forecasted 
until at least 2025 (Landsiedel et al., 2010).  The adverse effects of nano-TiO2 have been 
studied previously both in vitro and in vivo (Johnston et al., 2009; Iavicoli et al., 2011; Zhang 
et al., 2012).  The majority of studies on nano-TiO2 toxicity in cultured human cells have 
shown the induction of cytotoxicity, genotoxicity, inflammation, and reactive oxygen species 
(ROS) production (Singh et al., 2009; Iavicoli et al., 2011).  Other studies have indicated that 
nano-TiO2 does not induce either DNA damage in human peripheral blood lymphocytes or 
DNA strand breaks in human lung cells (Bhattacharya et al., 2009; Hackenberg et al., 2011).  
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In vivo studies have also produced both positive and negative results for nano-TiO2 toxicity.  
In mice nano-TiO2 in their drinking water has been shown to induce 8-hydroxy-2'-
deoxyguanosine adducts, micronuclei formation, gamma-H2AX foci, and DNA deletions 
after ingestion in water (Trouiller et al., 2009).  On the other hand, nano-TiO2 failed to 
induce both DNA strand breaks as assessed by the comet assay in rats after intra-tracheal 
exposure (Naya et al., 2012), as well as micronuclei formation in mice after intravenous 
injection (Sadiq et al., 2012).   
Bio-distribution studies of nano-TiO2 in vivo have indicated that the liver is a primary 
target organ of exposure after oral administration as well as intraperitoneal and intravenous 
injection, making it an important focus for nanotoxicity studies (Wang et al., 2007; Fabian et 
al., 2008; Chen et al., 2009; Yamashita et al., 2011).  In vivo studies using nano-TiO2 
exposure have shown liver dysfunction, inflammation, oxidative damage, hepatocyte 
apoptosis, and gene expression of associated response pathways (Wang et al., 2007; Ma et 
al., 2009; Liu et al., 2009; Liu et al. 2010; Cui et al., 2010; Cui et al., 2011; Cui et al. 2012).     
Comprehensive toxicity studies of engineered nanoparticles require adequate 
physicochemical characterization of the nanoparticles in their dry state and after dispersion in 
treatment medium.  For example, nano-TiO2 has been shown to have higher toxicity in the 
anatase form compared to the rutile form (Sayes et al., 2006).  The need to discern the 
physicochemical characteristics of nanoparticles in biological medium has been made more 
apparent with the identification of the nano-bio interface and the adsorption of surrounding 
biological molecules (i.e. proteins) onto the surface of the nanoparticle (Lundqvist et al., 
2008; Nel et al., 2009; Casals et al., 2010).  The nano-bio interface has been shown to 
influence cellular uptake and toxicity (Maiorano et al., 2010; Monopoli et al., 2011; Tedja et 
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al., 2012).  Indeed, in vitro studies have shown that the presence of serum can alter the 
toxicity of nanoparticles (Corradi et al., 2012; Merhi et al., 2012; Prasad et al., 2013).   
Furthermore, the nano-bio interface adds a further layer of complexity when considering the 
various media used for in vitro studies, different target organ environments, and in vitro to in 
vivo extrapolations (Monopoli et al., 2011a).  With the advancement of nanoparticle-surface 
chemistries and potential uses of nano-TiO2 in consumer products and medical devices, it is 
important to determine the role of the nano-bio interface in cellular interaction and toxicity.   
We have shown previously that nano-TiO2 can have different agglomeration 
characteristics depending on the type of treatment medium in which they are dispersed 
(Prasad et al. 2013).  In our previous study, a serum-free medium (KGM) supplemented with 
either 0.1% bovine serum albumin (BSA) or 10% fetal bovine serum (FBS) produced 
different agglomeration profiles, with the FBS-supplemented KGM eliciting smaller 
agglomerates than that supplemented with BSA.  Additionally, the smaller particles in the 
medium supplemented with FBS was associated with increased cellular interaction, 
micronucleus formation, and fraction of cells in S-phase compared to the medium 
supplemented with BSA in human lung epithelial (BEAS-2B) cells.  Interestingly, in the 
same study the comet assay detected no differences in induced DNA damage between the 
treatment media. 
  The impact of the nano-bio interface on the physicochemical characteristics of nano-
TiO2 and subsequent biological effects are still unclear.  In this study we examined nano-
TiO2 dispersed in Dulbecco’s modified eagle medium (DMEM) supplemented with 0.1% 
BSA (referred to herein as DB) and DMEM supplemented with 10% FBS (referred to herein 
as DF) to identify the role of the nano-bio interface in HepG2 cells.  These studies were 
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designed to determine if the nano-bio interface differences shown in agglomeration, cellular 
interaction and micronucleus formation in our previous study are conserved with different 
cell types and under different culture conditions.   
We analyzed agglomeration by dynamic light scattering, cellular interaction by flow 
cytometry, DNA damage as assessed by the comet assay, and micronuclei formation.  
Furthermore, to determine adverse outcome pathways that may be associated with nano-TiO2 
exposure in HepG2 cells, we used immunocytochemistry to measure the phosphorylation of 
ataxia telangiectasia-mutated (ATM).  We have shown previously an upregulation of the 
ATM-checkpoint kinase 2 (Chk2) DNA damage-response pathway by nano-TiO2 in human 
dermal fibroblasts (Prasad et al., 2012).  Additionally, we used luciferase reporter genes to 
measure transcriptional activation of the inflammatory factors: nuclear factor-kappa-light-
chain-enhancer of activated B cells (NF-κB) and activator protein 1 (AP1). 
4.3 MATERIALS AND METHODS    
	  
4.3.1 Chemicals 
The TiO2 nanoparticles (86% anatase and 14% rutile as listed by the manufacturer) 
were obtained from Degussa (now Evonik, AEROXIDE® TiO2 P25, Parsippany, NJ). 
Particles were sonicated using a probe sonicator (Cole Parmer, Vernon Hills, IL).  For 
immunocytochemistry, rabbit monoclonal anti-phospho-ser1981-ATM (pATM) was 
purchased from Epitomics (Burlingame, CA).  Glucose and potassium chloride were 
purchased from Sigma-Aldrich (St. Louis, MO).    
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4.3.2 Particle Preparation and Characterization 
   For the DB and DF dispersions, pre-weighed nano-TiO2 were suspended in DMEM 
supplemented with 0.1% BSA (DB) or DMEM supplemented with 10% FBS (DF), 
respectively, at 1 mg/ml and probe sonicated at 7 W for 2 min on ice.  For the KB and KB-
Plus dispersions, pre-weighed nano-TiO2 were suspended in keratinocyte growth medium 
(KGM) supplemented with 0.1% BSA or KGM supplemented with 3.5 g/L glucose, 3.87 mM 
KCl, and 0.1% BSA.  Subsequent dilutions of DB, DF, KB, and KB-Plus were made to 500 
and 100 µg/ml for treatment.   
Nanoparticles were characterized in dry form using TEM by the University of 
Kentucky (contract # PR-NC-08-10414) and in medium using DLS and zeta potential 
measurement techniques as described previously (Sanders et al., 2011; Prasad et al., 2013).  
DB and DF preparations were diluted 1:10 in DMEM, whereas KB and KB-Plus preparations 
were diluted 1:10 in KGM. All preparations were subjected to dynamic-light scattering 
analysis for hydrodynamic diameter and zeta potential measurements and calculations.  
Approximately 1 ml of each concentration was placed in a sizing cuvette (Sarstedt, 
Nümbrecht, Germany) and measured with a Zetasizer Nano at 37 ºC (Malvern Instruments, 
Worcestershire, UK).  The refractive index used for the measurements was 2.51, reflecting a 
14% rutile, 86% anatase mixture.  For zeta potential each nano-TiO2 concentration was 
measured using a zeta-potential cuvette (Malvern Instruments, Worcestershire, UK).  All 
particle characterization measurements represent the mean ± SE of three independent 
experiments. 
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4.3.3 One-Dimensional Gel Electrophoresis 
  To determine the adsorbed proteins on the surface of the nano-TiO2, SDS-PAGE gel 
electrophoresis of the nanoparticles in each treatment medium and after incubation in cell 
culture medium for 24 h, was performed as described previously (Lundqvist et al., 2008; 
Maiorano et al., 2010; Tedja et al., 2012; Prasad et al., 2013).  Briefly, nano-TiO2 were 
diluted in KB, KB-Plus, DB and DF at 1 mg/ml and sonicated as described previously.  After 
incubation for 24 h, 1 ml of each suspension was transferred to a separate tube and 
centrifuged at 12,000 x g for 15 min.  The supernatant was aspirated, and the remaining 
pellets were washed with PBS and centrifuged again.  After the supernatant was removed, 
washed nano-TiO2 in PBS were mixed with 2X Protein Gel Loading Buffer (Fisher 
Scientific) and heated at 95º C for 10 min.  All samples (treatment medium alone, nano-TiO2 
in each treatment medium, and nano-TiO2 in cell culture medium) were loaded onto a 8-16% 
SDS-PAGE 1D gel (Thermo Scientific) along with a Fermentas PageRuler™ Plus protein 
ladder (Thermo Scientific), and a constant voltage of 125 V for 45 min was applied.  The gel 
was rinsed in distilled water for 15 min, stained using Gel Code Blue Stain (Thermo 
Scientific) for 3 h, followed by rinsing excess stain with distilled water for ~1 h.  Gel images 
were taken using a Gel Logic 2200 Pro imager and analyzed with MI SE 534 program 
(Carestream Health, Rochester, NY).  Three independent experiments were performed for 
each treatment medium.  
4.3.4 Cell Culture and Treatments   
  HepG2 and BEAS-2B cells were obtained from American Type Culture Collection 
(ATCC, Manassas, VA).  HepG2 cells were maintained in Dulbecco’s Modified Eagle 
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Medium supplemented with 10% FBS (DMEM, Fisher Scientific).  BEAS-2B cells were 
maintained in serum free keratinocyte basal medium (Lonza) supplemented with KGM 
SingleQuots Lonza.  For cell viability experiments HepG2 cells were seeded at 2.5 x 104 
cells/well in 96-well plates and cultured for 24 h.  Cells were exposed to nano-TiO2 for 24 h 
over a 10-point half log concentration range at 0 and 0.003 to 100 µg/ml in a final volume of 
200 µl for 24 h.  Stock solutions at 1 mg/ml were vortexed thoroughly and diluted.  Prior to 
treating the cells, each concentration in the 10-point ranged was also vortexed.   
For the cellular interaction, comet, and micronucleus assays, cells at 5.0 x 104 
cells/cm2 were seeded in T-25 flasks, incubated for 48 h, and then treated for 24 h with 
nanoparticles.  For treatment the nanoparticle preparations (DB and DF) were diluted 1:10 in 
DMEM to produce final concentrations of 0, 10, 50, and 100 µg/ml TiO2.  The KB and KB-
Plus preparations were diluted 1:10 in KGM to produce 0, 10, 50, and 100 µg/ml TiO2   For 
the MN assay the cells were treated at ~60% confluence to ensure growth-phase 
characteristics, and fresh medium was added with the cytochalasin-B treatment.  For the 
comet assay the cells were treated at ~80% confluence.  
 
4.3.5 Cell Viability 
Cell viability was assessed using CellTiter-Blue® Cell Viability Assay (ProMega, 
Madison, WI) according to manufacturer’s instructions with some modifications.  Briefly, 
cells were cultured and plated in clear 96-well plates as described above.  After a 24-h 
exposure the medium was aspirated, and 40 µl/well of CellTiter-Blue® reagent was added.  
The plate was then incubated for 2 h at 37ºC, and then centrifuged at 2500 rpm for 10 min.  
The supernatant was transferred to a new plate to avoid the confounding effects of nano-TiO2 
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on the plate reading.   Plates were read immediately after transfer using a Wallac Victor 3 
plate reader (Perkin Elmer, Waltham, MA).  Cell viability was assessed using three 
independent experiments.    
 
4.3.6 Flow Cytometry 
Cellular interaction of nano-TiO2 was determined by flow cytometry as described 
previously (Prasad et al., 2013; Zucker et al., 2010; Zucker et al. 2012; Suzuki et al., 2009).  
Briefly, cells were trypsinized, centrifuged at 135 x g for 10 min, resuspended in 0.5 ml of 
medium, and put directly on ice.  A BD FACSCalibur™ (BD Biosciences, San Jose, CA) 
flow cytometer containing a 488-nm laser, forward-scatter (FSC) diode detector, and 
photomultiplier tube side-scatter (SSC) detector was used in this study. Prior to each 
experiment, the instrument was checked for functionality and performance using Duke 3.0-
µm alignment beads (Zucker et al., 2012).  The instrument yielded coefficient of variation 
values below 2% on all the fluorescence channels at low flow rates using the alignment 
beads. The cytometer was set up to measure SSC logarithmically and FSC linearly.  The 
highest concentration of nanoparticles was run first to set the range for the maximum SSC 
signal and the minimum FSC signal. The treated values were normalized to control values.  
Cellular uptake of nano-TiO2 in HepG2 and BEAS-2B cells was assessed in three 
independent experiments. 
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4.3.7 Comet Assay 
 The comet assay was performed as described previously (Prasad et al., 2013).  Here,, 
10 µl of untreated and treated HepG2 cells at 106 cells/ml were added to 190 µl of 0.53% 
low-melting point agarose (LMP), and 90 µl were placed on two slides and covered by a 24- 
x 50-mm coverslip and placed on ice. After the agarose had solidified, the cover slip was 
removed, and another 90 µl of LMP was added, and a coverslip was placed on top.  The 
cover slip was removed again, and the slides were placed in 4ºC lysis buffer (5-M NaCl, 100-
mM EDTA, 10-mM Tris, 1% Triton X-100, pH 10.0) overnight at 4°C.  Following lysis, 
slides were rinsed with cold water and immersed in 4ºC denaturing electrophoresis buffer 
(300-mM NaOH, 1-mM EDTA) for 40 min. Electrophoresis was performed in buffer 4°C 
(pH > 13) for 20 min at 25 V (1.33 V/cm) and 300 mA.  Next, the slides were immersed in 
neutralizing buffer (0.4-M Tris-HCl, pH 7.5) for 15 min, dehydrated in 95% ethanol for 3 
min, and allowed to air dry. 
 After drying, slides were stained with 5X Sybr Gold® and viewed using fluorescence 
microscopy.  Images were collected using a 25X objective (Plan Fluor 25X, Nikon 
Microphot FXA), a Nikon B-2H filter, and an ORCA CCD camera (Hamamatsu).   Images 
were analyzed using Komet® version 5.5 (Andor Technology, Morrisville, NC); 50 images 
per slide and two slides per concentration were analyzed in each experiment.  Slides were 
coded before analysis so that the scorer had no knowledge of the treatment when obtaining 
the data.  Data were expressed as the mean ± SD of three independent experiments for each 
treatment medium and nano-TiO2 concentration tested along with untreated control cells and 
a positive control cells treated with 100 µM of methyl methanesulfonate for 1 h.  
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4.3.8 Cytokinesis-blocked MN Assay  
 The MN assay with acridine orange staining was performed as described previously 
(Prasad et al. 2013).  Briefly, HepG2 and BEAS-2B cells treated with nano-TiO2 for 24 h and 
then 5 µg/ml of cytochalasin B was added for 18 h to induce binucleation.  Cells were then 
resuspended in PBS at a density of 2 x 105 cells/ml.  The cells from 75 µl of cell suspension 
were deposited onto pre-cleaned slides using a Shannon CytoSpinTM centrifuge at 40 x g for 
5 min.  Slides were air dried, fixed in 100% methanol for 10 min, and stored at 20ºC. 
 Slides were stained with acridine orange diluted to a concentration of  40 μg/ml in a 
0.02-M phosphate buffer (pH 7.4) for 30-45 sec and washed twice with distilled water.  A 
24- x 55-cm cover glass was placed on the slide using Sorenson’s buffer (70 ml 0.1-M 
NaHPO4 and 30 ml 0.1-M KH2PO4, pH=7.4).  Slides were scored blindly using a microscope 
(Nikon Microphot FXA), dual bandpass filter (TRITC/FITC), and 20X objective (Plan 
Fluor).  One thousand binucleated cells were scored for the presence of MN for each 
exposure (Fenech et al., 2000; Kirsch-Volders et al., 2003).  Additionally, the cytokinesis 
blocked proliferation index (CBPI) was calculated for determination of cytostasis and as a 
marker of cytotoxicity (Kirsch-Volders et al., 2003).  Two independent experiments were 
conducted in both HepG2 and BEAS-2B cells for each nano-TiO2 concentration tested in 
each treatment medium along with untreated control cells and a positive control cells treated 
with 100 µM of methyl methanesulfonate for 24 h.   
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4.3.9 Immunocytochemistry 
 Immunocytochemsitry for pATM was performed as previously described (Prasad et 
al., 2012).  Briefly, cells were seeded in six wells of an eight-well chamber slide at a density 
of 2.5 x 104 cells/chamber. After 24 h to allow adherence to the slide, cells were treated with 
nano-TiO2 for 24 h in DB and DF or the positive control (5 Gy of ionizing radiation).  Cells 
in chamber slides were fixed in 10% formalin for 10 min and washed with phosphate 
buffered saline. Immunocytochemistry was carried out in the Bond Autostainer (Leica 
Microsystems Inc. Norwell, MA).  Antigen retrieval was performed for 30 min at 100oC in 
Bond-Epitope Retrieval solution 1 pH-6.0 (Cat. #AR9961). Slides were incubated with 
primary antibody for 8 h followed by antibody detection with the Bond Polymer Refine 
Detection System (DS9800).  Stained slides were dehydrated and cover-slipped. Positive and 
negative controls (no primary antibody) were included for each run. The results represent the 
mean ± SD of three independent experiments. 
Stained chamber slides were imaged digitally using the Aperio ScanScope XT 
(Aperio Technologies, Vista, CA). Digital images were stored and analyzed within the 
Aperio Spectrum Database. TMALabTM (Aperio) software was used to segment each 
compartment of the chamber slide, as an individual sector comprised of the 12 individual 
spots representing randomly selected areas. The expressions of the antibodies were measured 
using the Aperio Nuclear V9 (cell quantification) algorithm.  Algorithm parameters, 
including curvature threshold and min nuclear size, were tuned to achieve the optimal cell 
segmentation. The results were scored and are reported as % positive nuclei. Additionally, 
total nuclei scored/chamber were counted to determine differences in cell growth (Appendix 
IV, Supplemental Table 7). 
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4.3.10 Luciferase reporter gene assay  
The construction of lentiviral vectors and a stable HepG2 reporter gene cell lines for 
NFkB-luciferase and AP1-luciferase were done as described previously (Prasad et al., 
2013a).  Briefly, after cell treatment with nano-TiO2 in DB and DF or the positive control, 
hydroquinone, culture media were aspirated and cells were lysed with 50 µl of non-
denaturing lysis buffer (50 µl/well; 25-mM Tris phosphate, 2-mM trans-1,2-
diaminocyclohexane-N,N’N’,N’-tetraacetic acid monohydrate, 10% glycerol, 0.5% Triton-X 
100, 2-mM Dithiothreitol, pH 7.8) for 15 min at ambient temperature.  Luciferase activity 
was detected by adding 50 µl of luciferase-detection buffer (20-mM Tricine, 1.07-mM 
(MgCO3)4·Mg(OH)2·5H20, 2.67-mM MgSO4, 100-µM EDTA, 33.3-mM dithiothreitol, 270-
µM coenzyme A, 470-µM D-luciferin, 530-µM ATP, final pH 7.8).  Plates were read on a 
BMG FluoStar (Durham, NC) plate reader in luminescent mode with a 1-sec integration 
time.  Transcriptional activation was assessed in three independent experiments for each 
reporter gene. 
 
4.3.11 Statistical Analyses 
For the cytotoxicity and reporter gene assays, data were normalized to in-plate 
vehicle controls and are presented as mean fold change over vehicle ± standard error of the 
mean. Concentration-responses were fitted to four-parameter, non-parametric curves using a 
least squares (ordinary) fit method with GraphPad Prism 5 (San Diego, CA). 
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For immunocytochemistry, comet, micronucleus, and CBPI assays, statistical 
analyses were performed as described previously (Prasad et al., 2012; Prasad et al., 2013). 
Briefly, results are presented as the mean ± SD, and a one-tailed analysis of variance 
(ANOVA) was used followed by Fisher’s protected least-significant-difference test for post-
hoc comparisons to determine if the experimental treatments produced differences among 
each other or from the controls.  Results were considered statistically significant if p < 0.05.   
Specifically for the comet assay, a linear model was used to compare the slopes of the 
2 regression lines (one for each treatment medium) for the induced DNA damage versus the 
square root of the concentration. The induced DNA damage (i.e., % tail DNA of each treated 
concentration minus mean % tail DNA for the concurrent controls) was used as a measure of 
damage to normalize the data.  The slopes of the regression lines were compared assuming a 
common Y-intercept set to zero using Statgraphics Centurion XVI Version 16.1.05 (Statpoint 
Technologies, Inc., Warrenton, VA).  For the MN assay simple linear-regression analyses 
were performed with StatGraphics Centurion XVI for each concentration-response curve for 
each medium. 
 
4.4 RESULTS 
	  
4.4.1 Physicochemical characterization 
 Nano-TiO2 was evaluated as a dry substance by transmission electron microscopy 
(TEM) by the University of Kentucky (Appendix IV, Supplemental Table 5) as described 
previously (Sanders et al., 2010; Prasad et al., 2013).  In addition, we analyzed the protein 
corona (the proteins in the treatment medium that were adsorbed to the surface after 
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incubation for 24 h) in relation to the treatment medium alone and saw that proteins in the 
DB and DF medium adsorbed to the surface of nano-TiO2 (Appendix IV, Supplemental 
Figure 11).  Therefore, it is qualitatively shown that DF medium is composed of a variety of 
proteins whereas DB medium contains relatively few proteins (the most prevalent being 
bovine serum albumin). 
 For physicochemical characterization of nano-TiO2 in the DB and DF medium, the 
hydrodynamic diameter, polydispersion index, and zeta potential were measured at 0, 10, 50 
and 100 µg/ml immediately after sonication.  In Figure 15A, both DB and DF medium 
induced little increases in hydrodynamic diameter (0 µg/ml point: 23.82 nm ± 0.41 nm and 
9.24 nm ± 7.96 nm, respectively); therefore, no significant protein agglomeration confounded 
the results of the nano-TiO2 formulations.  In both treatment media, hydrodynamic diameter 
ranged from 244.10 nm to 373.23 nm.  Polydispersion index (PdI), a measure of the variance 
in size measurements, was in the range if 0.18 to 0.34 for nano-TiO2 in both media, 
indicating a relatively stable measurement (scale is from 0 to 1).  The zeta potential, a 
measure of electrokinetic potential that indicates the degree of repulsion between particles, of 
nano-TiO2 in both treatment media was in the range of -6.7 mV to -8.6 mV (Appendix IV, 
Supplemental Table 6).  For all three measurements (hydrodynamic diameter, PdI, and zeta 
potential) there were no significant differences with increasing concentration or between the 
media.  
 
4.4.2 Cell viability 
 No concentrations of nano-TiO2 in either treatment media elicited a significant 
decrease in % viability from the untreated controls (Appendix IV, Supplemental Figure 12).  
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The positive control, AgNO3, elicited significant decreases in cell viability from untreated 
controls at all concentrations tested with an EC50 = 0.3643 µg/ml.  
 
4.4.3 Cellular interaction with flow cytometry 
 Cellular uptake to the cytoplasm of cells can be evaluated by flow cytometry using 
side scatter (Zucker et al., 2010; Zucker et al., 2012; Zucker et al., 2012a; Prasad et al., 
2013).  By comparing the histogram of untreated controls to the nano-TiO2 treated HepG2 
cells for 24 h, cellular uptake can be quantified through a side scatter ratio 
(treated:untreated). In this study, increases in uptake were associated with increasing 
concentrations of nano-TiO2 in both treatment media.  As shown in Figure 15B, nano-TiO2 in 
the DB medium had slightly increased side scatter ratios at each concentration tested 
compared to the DF medium (10 µg/ml: DB- 1.77 DF- 1.38; 50 µg/ml: DB- 3.20 DF- 2.41 
100 µg/ml: DB-3.87 DF-3.11) .  However, the differences between the medium were not 
statistically significant.      
 
4.4.4 Comet assay 
 As depicted in Figure 16A, induced DNA damage after 24 h in HepG2 cells as 
measured by the comet assay was increased significantly with increasing concentrations of 
nano-TiO2 in both treatment media, indicating modest genotoxic effect (p < 0.05).  However, 
there was no effect between the media on induced DNA damage.  Simple regression analysis 
using a best-fit model (induced DNA damage vs. the square root of the concentration) 
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resulted in a significant increase in induced tail DNA with increasing concentration in both 
the DB (R2 = 60.48%, p = 0.0029) and DF medium (R2 = 77.19%, p = 0.0002). 
 
4.4.5 Micronucleus assay 
 Micronucleus formation was increased significantly with increasing concentrations of 
nano-TiO2 in both treatment media using analysis of variance (Figure 16B, p < 0.05).  Simple 
regression analysis using a best-fit model (# of micronuclei (MN)/ 1000 bi-nucleated cells vs. 
concentration) resulted in a significant increase in micronucleus formation with increasing 
concentration in DB (R2 = 89.44%, p = 0.0004) and DF medium (R2 = 95.64%, p < 0.0001). 
 Figure 16C illustrates the cytokinesis blocked proliferation index (CBPI), a measure 
of cytostasis that can be calculated using cells stained for the micronucleus assay (Kirsch-
Volders et al., 2003).  CBPI was decreased significantly with increasing concentrations of 
nano-TiO2 in both treatment media using analysis of variance (p = 0.0001).  Regression 
analysis using a best-fit model (CBPI vs. concentration) resulted in a significant decrease in 
CBPI with increasing concentrations in DB (R2 = 86.05%, 0.0009) and DF (R2 = 77.01%, p = 
0.0042) medium.  
 
4.4.6 Immunocytochemistry analysis of pATM 
 In Figure 17A, immunocytochemistry was used to identify the phosphorylation of 
ATM as a measure of the DNA damage response in HepG2 cells after a 24-h exposure to 
nano-TiO2.  In the DB medium, we found a significant increase in % pATM positive nuclei 
from untreated control cells at 1 µg/ml (47% ± 2%, p < 0.05).  In the DF medium, we found a 
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significant increase in % pATM positive nuclei from the untreated control cells at 1 µg/ml 
(49% ± 3.01%, p < 0.05).  In both DB and DF, 3 µg/ml of nano-TiO2 induced an increase in 
% pATM positive nuclei that was not statistically significant, most likely due to variability 
(DB: 46% ± 2.4%, p = 0.071; DF: 47% ± 6.3%, p = 0.077).  The positive control, 500 rad (5 
Gy) of ionizing radiation exposure also increased significantly the % pATM positive nuclei 
(DB: 84% ± 9.17%, DF: 88% ±6.32%, p <0.05).   
 
4.4.7 Transciptional activation of NF-κB and AP-1 
 NF-κB-luciferase and AP-1 luciferase HepG2 cells were treated with nano-TiO2 in 
DB and DF for 24 h.  In Figure 17B, 100 µg/ml of nano-TiO2 exposed NF-κB-luciferase cells 
in both DB and DF medium were elevated significantly from untreated control cells (p < 
0.05).  On the other hand, there was no significant elevation of transcriptional activation in 
AP-1 luciferase for HepG2 cells exposed to nano-TiO2 for 24 h (Figure 17C).  In both cases, 
the positive control, hydroquinone (HQ), was elevated significantly (p < 0.05) from untreated 
control cells at all concentrations tested (Appendix IV, Supplemental Figure 13).  
 
4.4.8 Protein Corona, Agglomeration, Cellular interaction, and Micronucleus formation with 
KB and KB-Plus 
	  
 To examine the differences between KB from our previous study and DB, we added 
the additional glucose (3.5 g/L) and KCl (3.87 mM) present in DMEM to KGM to create 
KB-Plus (Appendix IV, Supplemental Table 8).  As shown in Figure 18A, the dynamic light 
scattering measurements show no significant differences between the two media (p > 0.05).   
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Similarly in Figures 18B, 18C, and 18D, the cellular interaction, micronuclei, and 
cytokinesis-blocked proliferation index, respectively, were not significantly different 
between the two media (p > 0.05).  In Figure 19, SDS-PAGE analysis of the protein corona 
in KB, KB-Plus, and DB after 24 h incubation in cell culture medium (KGM, KGM, and 
DMEM supplemented with 10% FBS, respectively) indicates several proteins adsorbed to the 
surface in the HepG2 cell culture medium that are not present in the other preparations. 
     
 
4.5 DISCUSSION 
	  
 The liver represents an important translational target for engineered nanoparticles 
through a variety of exposure routes in humans.   In this study, we set out to determine 
cellular interaction and biological responses (cytotoxicity, genotoxicity, DNA damage 
response, and inflammation) of human hepatoma (HepG2) cells after exposure to nano-TiO2 
in DB medium and DF.  Although nano-TiO2 did not induce cytotoxicity in either medium, 
the particles were taken up by HepG2 cells in both treatment media and induced DNA 
damage (comet assay) and micronuclei.  Furthermore, nano-TiO2 in both treatment media led 
to increases in the phosphorylation of the DNA damage response protein ATM and 
transcriptional activation of the inflammation transcription factor NF-κB.    
 Others have studied the agglomeration, cellular interaction, cytotoxicity, and 
genotoxicity of nano-TiO2 in HepG2 cells; however, no single study has examined all 
parameters, particularly the impact of the protein corona (Nel et al., 2009; Donaldson et al., 
2010; Iavicoli et al., 2012).  One study found that nano-TiO2 that formed smaller 
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agglomerates (in the 100- 200 nm range) in one treatment protocol were taken up more than 
larger agglomerates formed in a separate treatment protocol for all concentrations tested (10, 
50 and 100 µg/ml) at 2, 24, 48, and 72 h (Lankoff et al., 2012).  The authors also examined 
cytotoxicity in larger versus smaller agglomerates, and found that nano-TiO2 was not 
cytotoxic at all concentrations tested at exposures of 24, 48, or 72 h.  Another study 
examined the effects of nano-TiO2 on HepG2 cells in one type of treatment medium 
(aggregate size ~200 nm) on cellular uptake, cytotoxicity, genotoxicity, and oxidative stress 
markers and found that nano-TiO2 increased oxidative DNA damage at concentrations as low 
as 1 µg/ml, induced micronucleus formation, reduced glutathione levels as well as increased 
lipid peroxidation, reactive oxygen species generation, and expression of p53, BAX, Cyto-c, 
Apaf-1, caspase-9, and caspase 3 (Shukla et al., 2011).  Lastly, a study found that nano-TiO2 
induced up-regulation of p53 and DNA damage response genes (mdm2, gadd45α, p21) in 
HepG2 cells (Petkovic et al., 2011). 
  In our study, we have confirmed effects shown in all three of these studies, where 
small agglomerates of nano-TiO2 were taken up by HepG2 cells and subsequently induced 
DNA damage and micronuclei.  Additionally, up-regulation of the DNA damage response by 
phosphorylation of ATM, and inflammation pathway-associated transcriptional activation of 
NF-κB was associated with nano-TiO2 exposure in both media.  There were no 
concentrations of nano-TiO2 in either medium that elicited a significant decrease in cell 
viability of nano-TiO2 in HepG2 cells.  Other cell types, such as A549 cells, have shown 
increases in cell death in vitro (Lanone et al., 2009; Iavicoli et al., 2012; Lankoff et al. 2012).  
Cell type may play a role in the toxicity of nano-TiO2; therefore, identification of and 
research on translational target tissues are important for future research.  
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In our previous study, nano-TiO2 in KGM medium supplemented with BSA elicited 
larger agglomerates (~1000-1500 nm range), less cellular interaction with BEAS-2B cells 
and no increases in micronuclei, whereas nano-TiO2 in KGM supplemented with FBS 
elicited smaller agglomerates (~200 nm range), higher cellular interaction with BEAS-2B, 
and increases in micronuclei (Prasad et al., 2013).  There are few studies in nanotoxicology 
in which well-characterized dispersions were used and where the the physicochemical 
properties of the nanoparticles in medium were associated with biological effects.   
Previous research has shown that ion and glucose concentrations may impact the 
nano-bio interface and subsequent cellular response.  More specifically, a study by Maiorano 
et al. (2010) examined the effects of cell culture media on protein-nanoparticle complexes 
and influence on cellular response of gold nanoparticles in HeLa and U937 cells.  The 
authors found a differential response in protein corona size, aggregation, uptake and toxicity 
of gold nanoparticles in DMEM versus Roswell Park Memorial Institute (RPMI) medium 
both supplemented with 10% FBS.  To understand the differences in agglomeration and 
cellular response, the authors focused on the composition of the medium and found that 
differences in the amount of glucose and ionic concentrations in DMEM led to increased 
protein corona formation compared to RPMI.  A study by Xu et al. investigated the selective 
binding of the components of DMEM, DMEM supplemented with FBS, and PBS to zinc 
oxide and copper oxide nanoparticles (Xu et al., 2012).  They identified the formation of 
nanoparticle-bio complexes resulting from the adsorption of medium components, including 
ions such as Na+, K+, and Cl-, independent of proteins.   
Therefore, in the present study we examined the differences in composition of KGM 
versus DMEM media as a potential cause for the differences between KB and DB on 
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agglomeration, cellular interaction, and micronuclei formation.  We added glucose and KCl 
to KGM to mimic the concentrations found in DMEM (referred to as KB-Plus), 
supplemented both treatment media with 0.1% BSA, dispersed nano-TiO2, and treated 
BEAS-2B cells for 24 h.  We found no differences between the KB and KB-Plus media on 
agglomeration, cellular interaction, and micronuclei formation.  Therefore, we conclude that 
the differences in cellular interaction and genotoxicity between KB and DB are not due to 
glucose and ionic concentration differences.   
Other possibilities to explain the reason for medium-based differences and results 
obtained for the two cell types may include the cell culture conditions for BEAS-2B cells 
versus HepG2 cells.  BEAS-2B cells were grown and sub-cultured in serum-free KGM 
medium whereas HepG2 cells were grown and sub-cultured in DMEM medium 
supplemented with 10% FBS.  Therefore, although the nano-TiO2 was initially coated with 
BSA in DB, after the 24-h exposure the serum proteins in the HepG2 cell culture medium 
may have bound passively to the surface of the nanoparticle, thereby impacting the cellular 
interaction and subsequent genotoxicity of the nanoparticle.  Further understanding of the 
complex and dynamic interactions between nanoparticles, medium, and subsequent cellular 
impact will provide important information in the sustainable development and use of 
nanoparticles (Albanese et al., 2012; Lai et al., 2012; Pelaz et al., 2012).    Additionally, cell 
type may also influence cellular uptake and biological response to nano-TiO2 (Lankoff et al, 
2012)    
In conclusion, nano-TiO2 exposure to HepG2 cells for 24 h results in increased 
cellular interaction measured using flow cytometry, induced DNA damage measured with the 
comet assay, micronuclei formation, phosphorylation of ATM, and transcriptional activation 
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of NF-κB in treatment medium containing either 0.1% BSA or 10% FBS.  Although the 
cellular interaction and genotoxicity of nano-TiO2 in BSA-supplemented DMEM reported 
here are not consistent with the results from our previous study with BSA-supplemented 
KGM (Prasad et al., 2013), there are differences in cell type and culture conditions between 
the two studies that may account for these differing biological profiles.  Studies investigating 
the physicochemical characteristics of nanoparticles in medium of differing compositions, 
their dynamic role in cellular uptake, and biological response are paramount to the accurate 
assessment of nanoparticle-toxicity.    
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Chapter 5  
5.1 SUMMARY 
	  
 The overall goal of these studies was to determine the genotoxicity and cellular 
response to nano-TiO2 exposure using in vitro cell culture models representing three target 
organs: lung (human lung epithelial cell line), skin (human dermal fibroblasts), and liver 
(human hepatoma cell line).  With these completed studies, we have added to the knowledge 
base of the toxicological effects of nano-TiO2 and investigated the effects of the nano-bio 
interface.  Collectively, these studies provide further insight into the mechanisms of nano-
TiO2 genotoxicity.  
 In aim #1, we initially set out to assess the impact of three treatment media differing 
by their protein content on the agglomeration of nano-TiO2 and the effects on two well- 
known genotoxicity assays, the comet assay and the cytokinesis-blocked micronucleus assay, 
using human lung epithelial (BEAS-2B) cells as a cell culture model.  We found that the 
medium supplemented with 10% fetal bovine serum (KF) elicited nano-TiO2 agglomerates in 
the range of 200-300 nm, which were significantly smaller than the agglomerates formed in 
medium supplemented with bovine serum albumin plus surfactant (DM) as well as the 
medium supplemented with bovine serum albumin alone (KB).  The comet assay showed a 
concentration-dependent increase in induced DNA damage for all three media; however, the 
level of DNA damage was not significantly different among these three media.  The 
	  
94 
	  
micronucleus assay, however, showed concentration-dependent increases in the KF medium 
only, whereas no micronuclei were induced in KB and DM media.   
We then used flow cytometry to show that nano-TiO2 in KF medium showed the 
greatest interaction/uptake with the BEAS-2B cells compared with KB and DM.  Further, 
flow cytometry analysis of the cell cycle in BEAS-2B cells after treatment in all three media 
resulted in an increased percentage of cells in S phase in the KF medium, whereas the 
majority of cells treated with nano-TiO2 in KB and DM were in the G1 phase.  Together, the 
flow cytometry data underscored the differences in cellular interaction and cellular response 
to nano-TiO2 in KF medium versus DM and KB.  From this aim, we concluded that the 
serum proteins in the KF medium adsorbed to the surface of nano-TiO2, inducing smaller 
particle agglomerates.  These smaller agglomerates were able to interact with the cell without 
arresting the cell cycle in G1, thereby allowing the induced DNA damage detected by the 
comet to be processed into micronuclei.   
Due to the effects seen from aim #1, in aim #2 we set out to analyze the DNA damage 
response to nano-TiO2 in medium supplemented with 10% fetal bovine serum using two 
established pathways as a guide.  The ATM-Chk2 DNA damage response pathway has been 
associated with the DNA damage induced by ionizing radiation exposure, whereas the ATR-
Chk1 pathway has been associated with DNA damage induced by ultraviolet light exposure.  
We used the model system of human dermal fibroblasts to represent a skin exposure to assess 
whether nano-TiO2 induced either of these pathways.  Further, we analyzed H2AX (a marker 
of double strand breaks) as well as DNA synthesis and new-origin firing using a DNA 
combed fiber-staining technique.   
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In this aim we concluded that nano-TiO2 in medium supplemented with 10% fetal 
bovine serum upregulated the ATM-Chk2 intra-S checkpoint pathway, thereby inhibiting 
DNA synthesis and new origin firing.  In addition, the DNA damage induced by nano-TiO2 
in vitro were likely double strand breaks based on the increased phosphorylation of H2AX, 
ATM-Chk2 pathway (associated with double strand break DNA damage response), and 
inhibition of DNA synthesis and new origin firing.  These results suggest similarities in the 
DNA damage response pathway of nano-TiO2 to that of ionizing radiation. 
In aim #3 we determined if the conclusions from aim #1 and aim #2 were conserved 
in a different cell type.  Therefore, we used a human hepatoma (HepG2) cell line to represent 
a potential liver exposure.  We examined nano-TiO2 in two media types, one supplemented 
with bovine serum albumin (DB) and the other supplemented with 10% fetal bovine serum 
(DF).  When examining the agglomeration of nano-TiO2 in these two media, we found no 
differences in the particle sizes.  We then performed the comet and micronucleus assays in 
HepG2 cells and found that both treatment media induced concentration-dependent increases 
in induced DNA damage and micronucleus formation; however, there were no differences in 
the levels of DNA damage when comparing the two media.  We also showed an increase in 
the phosphorylation of ATM and transcriptional activation of the inflammatory marker NF-
κB.   
To examine the differences between aim #1 and aim #3, we identified the contents of 
the basal medium and found that DMEM used in aim #3 had higher concentrations of 
glucose and potassium chloride than the KGM used in aim #1.  Therefore, we increased the 
glucose and potassium chloride concentrations in KGM to equal that of DMEM in a new 
medium (KB-Plus) to test the hypothesis that the glucose and potassium chloride 
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concentration differences accounted for some of the differences seen in biological responses.  
We analyzed the effects of KB and KB-Plus on nano-TiO2 agglomeration and subsequent 
impact on cellular interaction, comet, and micronuclei in BEAS-2B cells and found no 
differences.   
Lastly, to address this issue, we analyzed the protein adsorption of KB, KB-Plus, and 
DB after incubation in the cell culture medium used to grow the BEAS-2B cells (for KB and 
KB-Plus experiments) and HepG2 cells (for DB experiment).  Here we found that the 
medium used to grow the HepG2 cells (DMEM supplemented with 10% fetal bovine serum) 
induced several proteins to adsorb to the surface of nano-TiO2 that were not seen with the 
BEAS-2B growth medium (serum-free KGM).  Therefore, we concluded that the differences 
shown in aim #1 and aim #3 were due to differences in both cell type and culture conditions. 
5.2 CONCLUSIONS 
	  
 As shown Figure 20, the collective approach from all three aims was to identify the 
genotoxic potential of nano-TiO2 using the comet and micronucleus assays, the ability to 
interact with cells using flow cytometry, and the ability to induce key mediators of DNA 
damage response and inflammation pathways using three cell culture models.  Taken 
together, we have shown: 
• Protein corona formation on the surface of nano-TiO2 can impact the nano-bio 
interface, change cellular interaction, and biological responses 
• Smaller agglomerates of nano-TiO2 can be taken up more by cells without 
inducing cell cycle arrest in G1, thereby allowing induced DNA damage to be 
processed into micronuclei in BEAS-2B cells 
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• Nano-TiO2 in medium that facilitates increased cellular interaction induces the 
upregulation of the ATM-Chk2 DNA damage response (similar to ionizing 
radiation) and NF-κB inflammation pathways 
• Nano-TiO2 likely induces DNA double strand breaks 
• The impact of cell type and cell culture conditions must be considered when 
analyzing in vitro studies for regulatory risk assessment of engineered 
nanoparticles 
 
The results from these studies provide a thorough analysis of the culture conditions 
and preparation of nano-TiO2 as well as the impact of the nano-bio interface on the 
genotoxicity and cellular response to nano-TiO2 in vitro.  The studies also provide guidance 
as to factors to consider when assessing the toxicity of nano-TiO2 in vivo, such as the impact 
of exposure route on nanoparticle-protein interactions and the target organ of interest.  With 
the increased usage of in vitro high throughput screening and high content screening 
approaches to address the safety analysis of engineered nanoparticles (Damoiseaux et al., 
2011), it is important to understand the intricacies of their novel physicochemical properties 
and the impact on toxicity testing.  The studies presented here have shown the potential for 
the type and concentration of protein in the medium and the cell type to influence the cellular 
interaction and genotoxicity of nano-TiO2 in vitro.  
Each of the study aims fits into the broader context of nanoparticle toxicology hazard 
evaluation by providing information that can be broken down into four major categories 
(Figure 21): physicochemical characterization, concentration-associated responses, 
cellular/tissue model, and biological endpoints. 
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A thorough physicochemical characterization of the nanoparticles can help identify 
what attributes of the particles can lead to any observed toxicity.  Although there is debate 
within the nanotoxicology field on the attributes of engineered nanoparticles that require 
assessment, it has been suggested that size, shape, surface area, crystal structure, 
agglomeration, composition, surface chemistry, charge, and solubility be considered 
(Warheit et al., 2008). Early studies performed on the genotoxicity of titanium dioxide 
nanoparticles did not characterize several of these parameters.  Furthermore, with the 
identification of the protein corona and its impact on nanoparticle properties and toxicity, it is 
essential to define the components of biological medium and the in vitro preparation 
procedures that can play a role. A major goal of this dissertation was to characterize 
adequately the proteins adsorbed to the nanoparticle surface and to observe subsequent 
differences in agglomeration, cellular interaction, and genotoxicity.  We were able to provide 
a systematic assessment of titanium dioxide nanoparticles dispersed in several different 
media and noted the differences that existed between protein supplementation as well as cell 
culture medium used.  It is therefore recommended that the physicochemical properties of 
engineered nanoparticles be examined for their dry form characteristics as well as in relevant 
biological/dispersion media to mimic real-world exposure conditions.  
One of the largest knowledge gaps in the nanotoxicology literature is the 
identification of real-world environmental exposure concentrations in humans.  In toxicity 
studies, the selection of doses is complicated by the lack of exposure data available to guide 
study design (Johnson et al., 2013).  In Aim #1, we examined concentrations of titanium 
dioxide nanoparticles that were in the range of several other in vitro studies, particularly 
those performed in BEAS-2B cells (Appendix I).  In Aim 2, we analyzed effects at lower 
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concentrations to determine if significant effects could occur in canonical pathways 
associated with the DNA damage response without significant cytotoxicity in human dermal 
fibroblasts.   In Aim #3, we kept the concentration range consistent with Aim #1 for the 
genotoxicity studies, and examined a range of concentrations using the reporter-gene assay 
with the initial goal of establishing lowest observed adverse effect levels (which were unable 
to be determined due to the modest increases in transcriptional activation).  The 
concentration ranges to test for nanotoxicology still remain uncertain due to the lack of real-
world exposure data.  Therefore, we recommend that until more studies can reliably assess 
exposure concentrations to guide toxicology studies, using multiple concentrations to assess 
biological effect, using biologically relevant treatment medium, and testing potential targets 
of exposure are paramount to advancing the field. 
 The ability to perform reliable in vitro studies will be important to minimize animal 
use and develop alternative testing strategies.  In Aim #1, we attempted to replicate several 
exposure routes using different treatment medium compositions.  We predicted from this 
study that exposure route might play a role in the toxicity of titanium dioxide nanoparticles.  
Other studies have shown the influence of proteins on the toxicity of other types of 
engineered nanoparticles; however, the trends are not always the same.  For example, Hauck 
et al. (2008) showed that the addition of serum decreased the toxicity and cellular uptake of 
gold nanoparticles in HeLa cells.  We examined three cell types reflecting three different 
target organs: lung, skin and liver.  However, there are limitations to consider when using 
one cell type to predict the response of an organ.  In vitro models will play a large role in the 
elucidation of mode of action as well as identification of the physicochemical properties that 
are associated with nanoparticle toxicity.  We recommend that co-culture and 3D models be 
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applied in future studies to reflect more accurately the target organs being exposed to 
nanoparticles in a real-world setting.   
 To ensure the sustainability of engineered nanoparticles, it is important to understand 
the potential risks they pose to human health.  Biological endpoints are critical in this 
understanding, and in our studies we focused on the genotoxicity and associated cellular 
responses related to titanium dioxide.  We were able to show a genotoxic response in three 
separate cell types, as well as the up-regulation of an ionizing radiation-like DNA damage 
response.  We also noted the impact of cell type in the genotoxic response to titanium dioxide 
nanoparticles under different treatment conditions.  We recommend that these studies be used 
to guide more complex in vitro and in vivo studies in order to provide adequate risk 
assessment for regulatory purposes.  
Overall, there is still much uncertainty on the potential human health risks associated 
with engineered nanoparticle exposure.  The primary data gaps associated with nanoparticle 
hazard evaluation are in the physicochemical characteristics, exposure route/concentrations, 
and their bio-distribution.  In our study we were unable to make a general prediction 
regarding the in vitro genotoxicity of nano-TiO2 due to limitations presented by the 
differences in biological response due to cell type and culture conditions.  Furthermore, with 
the abundance of novel nanoparticles available as well as those currently being developed, in 
vitro toxicity testing will play a critical role in developing our understanding of these risks.  
The studies presented here and others have underscored the unique issues that exist when 
dealing with engineered nanoparticles.  These results show that nanoparticle-preparation 
procedures and physicochemical properties in dry form, treatment medium, and cell culture 
medium, along with concentration and cell type, influence the genotoxicity of nano-TiO2.  
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Therefore, there is limited ability to make a general prediction regarding the in vitro 
genotoxicity of nano-TiO2.  
5.3 LIMITATIONS 
	  
Although the results of this dissertation have helped to identify the impact of the 
nano-bio interface on the genotoxicity of nano-TiO2, there are some limitations to the studies 
that should be acknowledged.   
 First, there are a variety of confounding factors when dealing with engineered 
nanoparticles in classical toxicology assays.  Most importantly is the ability for nanoparticles 
to adsorb certain wavelengths that are used in colorimetric cytotoxicity assays.  We 
attempted to solve this issue by using mainly microscopy methods to analyze cytotoxicity, 
but with that comes the potential for human error.  Additionally, nano-TiO2 agglomerates 
became so large in certain treatment media that the replicate slides in genotoxicity assays had 
to be increased in order to analyze the appropriate amount of cells.  Again, with microscopy 
methods, the potential for human error when scoring exists.  To address this, we conducted 
blind studies where the scorer did not know the sample that he was scoring. 
 Next is the obvious limitation of using cell culture models to depict real world 
exposure scenarios.  The particular models we used, BEAS-2B cells, human dermal 
fibroblasts, and HepG2 cells all have their individual limitations.  With BEAS-2B cells, we 
were using a SV-40 transformed human epithelial lung cell line in order to mimic a lung 
exposure.  With human dermal fibroblasts, we were using a cell line for which we had 
standardized the methodology for assessing DNA damage response pathways; however, 
these cells were not the best to model a skin exposure to nano-TiO2 in healthy humans 
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because it has been shown previously that nano-TiO2 does not pass through the intact normal 
epidermis (Sadrieh et al., 2010).  HepG2 cells, representing liver exposure, are human 
hepatoma cells; therefore, there were some issues with determining markers of DNA damage.  
In particular, we were unable to assess phosphorylation of H2AX due to the high background 
phosphorylation present in the cell line to begin with (data not shown).  In addition, although 
in vitro models have allowed for the identification of adverse outcome pathways, high-
throughput data collection, and low cost toxicology studies, they are not as applicable to risk 
assessment as in vivo studies.  Therefore, it is my opinion that the in-depth studies presented 
here should be used to guide targeted animal model studies to be able to correctly analyze the 
role of the nano-bio interface of engineered nanoparticle toxicity that would be relevant to 
humans.    
 A limitation of this study is in the applicability to real-world exposures.  One of the 
main issues with nanotoxicology is the lack of information regarding the potential for 
environmental exposure (i.e. primary exposure routes, concentrations, target tissues, etc.).  In 
our study many of the effects were statistically significant only at a concentration of 100 
µg/ml.  Although concentrations of nano-TiO2 can be up to 10% of total volume (Weir et al., 
2012), the likelihood of the average person being exposed to an intracellular concentration in 
the range of 10-100 µg/ml is very low.  Gangwal et al. (2011) suggested that a 30-400 µg/ml 
in vitro 24-h exposure concentration range was similar to a high occupational exposure over 
45 years, whereas a short-term exposure would be 1-2 fold lower. Therefore, the majority of 
concentrations used in this study that elicited a significant effect are not relevant for the 
general population.  However, this remains to be proven experimentally.  
103 
	  
 Lastly, a major goal of this study was to analyze an intricate nuance of engineered 
nanoparticles: the nano-bio interface.  In examining the limitations of these studies a priori, 
the specificity of the questions being asked required more controls being used to determine if 
the nanoparticle-protein interactions are truly the cause of the increased uptake and 
genotoxicity.  For example, in aim #1, a nano-TiO2 without any proteins in the medium could 
have been tested.  In aim #2, we could have analyzed more than one nanoparticle dispersion 
method.  In aim #3, we could have also used primary hepatocytes to compare the results with 
those of the HepG2 cell line.   
The impact of the nano-bio interface on the toxicity of engineered nanoparticles is 
extremely important in their safety assessment, especially when considering that targeted 
therapies using nanoparticles are on the horizon for complex diseases such as cancer and 
diabetes.  Therefore, studies that can reduce the number of confounding factors explored in 
the studies presented here are needed to assure the safety of engineered nanoparticles.  
Specifically, if the nano-TiO2 and culture medium interactions could be assessed more 
completely during the treatment period, and the complex interactions of the protein corona 
and the cell could be analyzed more thoroughly, an improved understanding could be made 
on the impact of the nano-bio interface on the ultimate health effects of engineered 
nanoparticles.       
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FIGURES AND TABLES 
Figure 1. Potential consumer and environmental exposures to humans of engineered 
nanoparticles.  With this increased bioavailability, comprehensive toxicity studies will be 
necessary to address public health implications.  Adapted from Stensberg et al., 2011. 
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Figure 2. The nano-bio interface.  Taken from Nel et al (38), this figure is a depiction of a 
potential interaction of the cell membrane with a nanoparticle that has absorbed components 
of the suspending medium (whether it be proteins, surfactants, lipids, etc.).  This may play a 
role in the cytotoxic and genotoxic potential of nanoparticles. 
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Figure 3. Representative SEM images of TiO2 nanoparticles dispersed in A) KB medium, B) 
DM medium, and C) KF medium at 200 µg/ml.  Magnification: ~18,000x (large image) and 
~3,000x (smaller image); the large figures are a 6X magnification of the small (inset) figures.  
These images show that the nanoparticles form fewer and smaller agglomerates in KF 
medium (C) than in the other two media (A,B).  
 
 
 
 
 
 
A) 
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Figure 4.  Characterization of TiO2 nanoparticles in treatment media by dynamic-light 
scattering.  Mean hydrodynamic diameter (d.nm) was determined for all three treatment 
media from 0 to 100 µg/ml at (A) t = 0 h and (B) t = 24 h.  Data are represented as mean 
± SD of three independent measurements; *p < 0.05 denotes a significant increase from 
KF treatment; †p < 0.05 denotes a significant increase from DM treatment. 
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Figure 5. Comparison of cellular interaction of TiO2 nanoparticles in three different 
dispersion media (KF, KB, and DM) as revealed by flow cytometer side scatter.  (A) Side-
scatter histogram profile of cells after exposure to 0, 10, 20, 50, and 100 µg/ml TiO2 
nanoparticles.  (B) A representative figure of the mean cell size from the histograms shown 
in Figure 2A is represented as the ratio of treated to control cells (0 µg/ml).  (C) 
Representative dark-field microscopy image of BEAS-2B cell after a 24-h exposure to TiO2 
nanoparticles stained with 40 µg/ml of acridine orange.  A 3-color image was acquired using 
a Nikon E-800 microscope using a FITC filter to observe the nucleus and a TRITC filter to 
observe the cytoplasm.  These fluorescent images were then combined with a dark-field 
image (white).  The Nikon Plan Fluor 60x lens was used with the iris set ~0.8 NA; 
magnification was 600x.    
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Figure 6. The effect of three different media on the induction of DNA damage (% tail DNA) 
in the comet assay by TiO2 nanoparticles in BEAS-2B cells after a 24-h exposure.  Data are 
from three independent experiments normalized by subtracting concurrent negative controls 
(KB: 2.8 ± 0.3 %, DM: 3.7 ± 1.6 %, KF: 3.2 ± 0.6 %). The positive control (MMS) at 100 
µM was used concurrently with each independent experiment (*p <0.05 from untreated 
control). Comparison of regression lines showed that there was no effect of medium 
composition on the induction of DNA damage by the nanoparticles; however, a small but 
statistically significant increase in DNA damage was shown with increasing concentration (p 
= 0.0006, R2 = 0.38).  All concentrations in all treatment media induced DNA damage that 
was significantly greater than the concurrent negative control except for two points:  10 µg/ 
ml in KF and 50 µg/ ml in DM.  
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Figure 7. The effect of medium composition on the induction of MN in BEAS-2B cells 
treated with TiO2 nanoparticles for 24 h.  Data are from two independent experiments.  The 
positive control (100 µM MMS) was used concurrently with each independent experiment 
and induced significant MN in all treatment media (KB: 71.0 ± 4.2 MN/1000 BN, DM: 71.0 
± 2.8 MN/1000 BN, KF: 69.5 ± 3.5 MN/1000 BN, *p < 0.05 from untreated control).  (A) 
Statistical analysis showed that there was no significant induction of MN by TiO2 
nanoparticles in DM or KB media (p = 0.20, R2 = 0.20; p = 0.35, R2 = 0.11, respectively). 
However, there was a highly significant induction of MN in cells treated in KF medium (p < 
0.0001, R2 = 0.89).  (B) Cytokinesis-blocked proliferation index (CBPI) showed no 
difference in treatment medium on cytostasis; however, there was an effect of concentration 
(p < 0.05). 
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Figure 8. The effect of medium composition on the cell cycle in BEAS-2B cells treated with 
TiO2 nanoparticles for 24 h.  Data are from two independent experiments.  Cell-cycle 
analysis showed that cells treated with TiO2 nanoparticles in the KF medium elicited a 
significant concentration-dependent increase in % of S-phase cells (p = 0.002, R2 = 0.82), 
whereas the cells treated with TiO2 nanoparticles in the KB and DM media did not.   
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Figure 9. Physical characterization of titanium dioxide nanoparticles in dry form using 
scanning electron microscopy. 
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Figure 10. Cell viability of human dermal fibroblasts treated with titanium dioxide 
nanoparticles using trypan blue dye exclusion assay.  Data expressed as mean ± SD. *p < 
0.05 compared to untreated control (0 μg/ml), n = 4. 
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Figure 11.  Immunocytochemical analysis of titanium dioxide nanoparticle exposure in 
human dermal fibroblasts show phosphorylation of (A) H2AX (B) ATM, and (C) Chk2 after 
24 h. Data expressed as mean ± SD, 5 Gy of ionizing radiation (IR) was used as a positive 
control. *p < 0.05 compared to untreated control (0 μg/ml), n = 3.  
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Figure 12. Replication dynamics of DNA combed fibers after treatment of human dermal 
fibroblasts with titanium dioxide nanoparticles.  Decreases were seen in A) relative DNA 
synthesis, as measured by relative length of green tracks in active replicons, and B) relative 
origin firing, as measured by number of green only tracks.  Data expressed as % of untreated 
control. Data expressed as mean ± SD.  *p < 0.05 compared to untreated control (0 μg/ml), 
n=3.  
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Figure 13.  A) Representative western blot of human dermal fibroblasts exposed to titanium 
dioxide nanoparticles for 24 h.  Positive control (PC) used in all western blots was 5 J/m2 
UV-C.  β-actin served as a loading control.  Thephosphorylated/unphosphorylated ratio 
normalized to 0 µg/ml is shown for B) pATM/ATM and C) pH2AX/H2AX. Data expressed 
as mean ± SD.  *p < 0.05 compared to untreated control (0 μg/ml), n=3.  
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Figure 14.  Intra-S checkpoint signaling in response to titanium dioxide nanoparticle 
exposure for 24 hr.  
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Figure 15. Characterization of nano-TiO2 in DB and DF medium after exposure of HepG2 
cells for 24 h.  (A) Hydrodynamic diameter (d. nm) determined by dynamic-light scattering 
was used as a measure of nanoparticle agglomeration/size for nano-TiO2 in media.  Data are 
expressed as mean ± SD, n =3.  (B) Cellular uptake was assessed by flow cytometry; the 
side-scatter ratio is calculated as the mean of the treated histogram/mean of the untreated 
histogram.  Data are expressed as mean ± SD. 
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Figure 16.  Assessment of genotoxicity in HepG2 cells after exposure to nano-TiO2 for 24 h.  
(A) Induced DNA damage assessed by the comet assay.  (B) Induced micronuclei expressed 
as number of micronuclei per 1000 binucleated cells (BN). (C) Cytokinesis Blocked 
Proliferation Index (CBPI) was used as a marker of cytostasis.  The positive control used for 
all three experiments was 100-µM methyl methane-sulfonate (MMS).  For the comet assay, 
the exposure to the positive control was for 1 h, whereas it was 24 h for the micronucleus 
assay and CBPI. Data are expressed as mean ± SD. *p < 0.05 from untreated control, n = 3 
for comet assay, and n = 2 for micronucleus assay and CBPI.  
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Figure 17.  DNA damage and inflammatory responses of HepG2 cells after exposure to 
nano-TiO2 for 24 h.  (A) % positive pATM nuclei was assessed by immunocytochemistry at 
0, 1, and 3 µg/ml as well as the positive control, which was 5 Gy of ionizing radiation (IR).  
(B) NFkB transcriptional activation was evaluated by NFkB-luciferase reporter genes.  (C) 
AP1 transcriptional activation was evaluated by AP-1-luciferase reporter genes.  For both 
luciferase reporter gene assays, hydroquinone (HQ) was used as a positive control (see 
Supplemental Figure 2).  Data are expressed as mean ± SD.  *p < 0.05 from untreated 
control, n =3 for each experiment. 
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Figure 18.  The effects of glucose and ionic concentrations in cell-culture medium on 
agglomeration, cellular interaction, and genotoxicity in BEAS-2B cells.  Nano-TiO2 
dispersed in KB and KB-Plus were examined for A) dynamic light scattering of nano-TiO2, 
B) cellular interaction in BEAS-2B cells as assessed by flow cytometry, C) micronucleus 
formation, and D) CBPI.  The positive control used for micronucleus formation and CBPI 
experiments were 100-µM methyl methane-sulfonate (MMS).  Data are expressed as mean ± 
SD, n = 3 for dynamic light scattering flow cytometry and n = 2 for micronuclei and CBPI, 
*p<0.05 from untreated control. 
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Figure 19. Proteins adsorbed to the surface of nano-TiO2 in treatment medium and after 24 h 
in cell culture medium using 1D SDS-PAGE gel electrophoresis.  Nano-TiO2 were 
centrifuged and washed in phosphate buffered saline prior to gel loading.  1) KB, 2) KB in 
KGM, 3) KB-Plus, 4) KB-Plus in KGM, 5) DB, 6) DB in DMEM w/ 10% FBS.  Arrows 
refer to different proteins in lane 6 compared to other 5 lanes. 
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Figure 20.  Compilation of the measurements made in all three studies.  Green indicates the 
assay was positive, red indicates the assay was negative, and indicates no change in the 
assay. 
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Figure 21.  Four major categories of nanotoxicology studies and associated information 
garnered from the dissertation aims in each category. 
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 Table 1. Physical characteristics of TiO2 nanoparticlesa 
     Characteristic                                              Result 
Primary Particle Size 27.5 nmb 
Size Range  14.2-64.6 nmb 
Surface Area 49 m2/gb 
% Purity 95.1%b 
Crystal Form 86% anatase/14% rutileb  
Elemental Analysis Ti = 59.95%c 
a Data from the University of Kentucky (see Materials and  
Methods).41,59 
bSize, surface area, purity, and crystal form of P25 TiO2  
received from manufacturer were measured independently. 
Approximately 150 dry particles were examined by TEM. 
cElemental analysis by ICP/MS.  Because the sample showed 
high purity, a set of 31 elements were checked to find  
contaminants. The levels of contaminants in the highest  
concentration were: Co (971 and 1002 ppm),  
K (350 and <0.05 ppm), SiO2 (1578 and 1219 ppm) and  
V (303 and 315 ppm).
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Table 2. TiO2 nanoparticle characterization in three treatment media and H2O measured by dynamic 
light scatteringa 
 
a Data are the mean ± SD of three independent measurements. 
b Not tested 
 
 
 
 
 
 
Medium  Concentration (µg/ml) 
Size 
 (nm)  
Size after 24 h 
at 37 °C 
(nm) 
PdI 
PdI 
after 24 
h at 37 
°C  
Zeta 
Potential 
(mV) 
KB 
10  437.7 ± 115.3  513.8 ± 24.8 0.569 ± 0.152	  
0.540	   ± 
0.072	   -0.53 ± 0.8 
20  712.4 ± 157.96  714.7 ± 223.7 
0.630 ± 
0.116	  
0.844	   ± 
0.149	   -5.14 ± 2.0 
50  1040.5 ± 285.7 1271.3 ± 148.8 
0.411 ± 
0.123	  
0.614	   ± 
0.189	   -6.34 ± 1.5  
100  1580.3 ± 283.3 1605.8 ± 28.6 
0.523 ± 
0.236	  
0.788 ± 
0.069	   -7.71 ± 0.4 
DM 
10  314.5 ± 69.8 360.4 ± 74.4 0.426 ± 0.120	  
0.324 ± 
0.135	   -2.99 ± 0.7 
20  467.9 ± 56.8 342.5 ± 161.1 0.338 ± 0.360	  
0.314 ± 
0.162	   -7.05 ± 3.2 
50  747.7 ± 321.4 736.6 ± 218.9 0.643 ± 0.145	  
0.643 ± 
0.145	   -2.63 ± 3.3 
100  926.9 ± 338.4 818.9 ± 55.2 0.733 ± 0.062	  
0.733 ± 
0.062	   -5.29 ± 1.6 
KF 
10  256.3 ± 10.3 223.3 ± 12.6 0.345	   ± 0.001	  
0.367 ± 
0.021	   -8.47 ± 0.2 
20  300.6  ± 15.2 302.9 ± 25.6 0.312 ± 0.022	  
0.299 ± 
0.028	   -6.71 ± 1.7 
50  357.9 ± 33.4 298.4 ± 4.9 0.239 ± 0.012	  
0.247 ± 
0.001	   -2.31 ± 0.4 
100  359.6 ± 22.3 288.8 ± 11.7 0.233 ± 0.023	  
0.215 ± 
0.010	   -7.04 ± 2.0 
dH2O 
10  309.7 ± 14.5 n/ab 0.36 ± 0.04	  	   n/a
b	   -8.7 ± 6.4 
20  282.5 ± 14.1 n/ab 0.32 ± 0.02	   n/a
b	   -17.2 ± 8.0 
50  276.9 ± 14.3 n/ab 0.27	   ± 0.02	   n/a
b	   -16.1 ± 3.4 
100  273.8 ± 5.9 n/ab 0.24	   ± 0.01	   n/a
b	   -10.2 ± 3.2 
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Table 3. Summary of results from Aim #1. 
 
Treat
ment 
group 
Media/pa
rticle 
preparati
on 
Media/cell 
treatment 
Size 
range 
at 0 h 
(X ± 
SD) 
Size 
range 
at 24 
h 
(X ± 
SD) 
Cell
ular 
upta
ke 
ratio 
(ran
ge) 
DNA 
damage 
(comet) 
Chromo
some 
damage 
(MN) 
Cell-
cycle 
Ranges 
(%) 
Comme
nts and 
results 
KB KGM + 
0.1% 
BSA, tip 
sonicate 
2 min 
KGM + 
0.01% 
BSA 
437.7 
± 
115.3 
nm – 
1580.3 
± 
283.3 
nm 
513.8 
± 
24.8 
nm – 
1605.
8 ± 
28.6 
nm 
3.58 
– 
12.1
5 
+ - G1: 
61-67 
S: 23-
29 
G2: 8-
10 
↑ 
aggregate
s 
↓ cellular 
uptake 
+ comet 
- MN 
No 
change : 
cell cycle 
DM PBS + 
0.6% 
BSA + 
0.001% 
DSPC, 
cup horn 
sonicate 
1 h (3 x 
20 min, 
10 sec 
on/off) 
KGM 314.5 
± 69.8 
nm – 
926.9 
± 
338.4 
nm 
360.4 
± 
74.4 
nm - 
818.9 
± 
55.2 
nm 
3.09 
– 
10.5
8 
+ - G1: 
65-69 
S: 23-
26 
G2: 8-
10 
↑ 
aggregate
s 
↓ cellular 
uptake 
+ comet 
- MN 
No 
change : 
cell cycle 
KF KGM + 
10% 
FBS, tip 
sonicate 
2 min 
KGM + 
1% FBS 
256.3 
± 10.3 
nm – 
359.6 
± 22.3 
nm 
223.3 
± 
12.6 
nm – 
288.8 
± 
11.7 
nm 
5.62 
– 
22.3
5 
+ + G1: 
47-49 
S: 35-
41 
G2: 
12-17 
↓  
aggregate
s 
↑ cellular 
uptake 
+ comet 
+ MN 
↑ S phase 
cells 
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Table 4. Size and zeta potential of nano-TiO2 in cell culture medium (DMEM + 10% FBS) 
using dynamic light scattering.  Data represented as mean ± SD of three independent 
experiments 
Concentration (µg/ml) Size (nm) Zeta Potential (mV) 
1 325.93 ± 10.34 -0.64 ± 0.51 
3 314.37 ± 20.41 -0.48 ± 0.11 
10 397.33 ± 17.48 -0.78 ± 0.05 
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APPENDIX I 
SUMMARY OF MAMMALIAN IN VITRO STUDIES ON THE GENOTOXICITY 
OF TITANIUM DIOXIDE NANOPARTICLES 
 
Citatio
n 
Nanoparticle Cell type Physico-
chemical 
Characterizatio
n 
Cytotoxici
ty 
Comet Micronucleu
s assay 
Gurr et 
al., 
2005 
TiO2 
anatase: 5, 
10, 20, 200, 
>200 nm; 
rutile: 200 
nm 
BEAS-2B Zetasizer: 10 
and 20 nm 
TiO2 produced 
aggregations of 
1000 nm, 
200 nm 
particles 
showed no 
aggregation. 
MTT: IC50 
after 3 day 
exposure = 
6.5 µg/ml 
w/Fpg: 10,20 
nm anatase, 
200 nm rutile 
at 10 µg/ml 
for 1 hr: + 
 
10, 200 nm 
anatase at 
10 µg/ml for 
24 hr: + 
Rahma
n et al., 
2002 
TiO2: ≥ 
20nm 
SHE 
Fibroblasts 
TEM Trypan 
blue 
increased: 
> 10 
µg/cm2 
(data not 
shown) 
 
N/A MN: + 
(12,24,48,66 
and 72 hr) 
kinetochore 
staining: - 
(clastogenic
) 
Wang 
et al., 
2007 
TiO2: 6.6 nm WIL2-NS N/A MTT: + 
130 µg/ml 
at 6, 24, 
48 hr; 
CBPI: + 
26, 65 
µg/ml at 
48 hr 
+ (65 µg/ml-
24 hr) data 
not shown 
 
+ (65 µg/ml: 
6, 24 hr; 26 
µg/ml: 48 
hr) 
Reeves 
et al., 
2008 
TiO2: 5 nm GFSk-S1 N/A  
NRR: 
w/UV: + 
dose-
dependent, 
w/o UV: - 
10 µg/ml at 2 
hr, 100 µg/ml 
at 24 hr : + 
N/A 
Hacke
nberg 
et al., 
2010 
TiO2 
anatase: <25 
nm 
Peripheral 
Blood 
Lymphocyt
es 
TEM: a high 
level of 
compact 
aggregations 
could be 
observed 
reaching 285 ± 
52 nm (mean ± 
se). 
Trypan 
blue: no 
significant 
cytotoxicit
y (24 hr 
exposure) 
20, 50, 100, 
200 µg/ml : - 
N/A 
Bhatta
charya 
et al., 
2009 
TiO2-NP (∅ 
< 100 nm) 
IMR-90, 
BEAS-2B 
TEM; SEM; 
Zetasizer: 
average particle 
size = 91 nm 
Trypan 
blue: 
BEAS-2B: 
-, IMR-90: 
+ 
BEAS-2B and 
IMR-90 : - 
 
N/A 
Falck 
et al., 
2009 
TiO2 
anatase: <25 
nm, rutile: 
BEAS-2B TEM: average 
agglomerate 
size: rutile: 4.5 
Trypan 
blue: 160 
µg/cm2 (48 
+: rutile = 24 
hr: 80 µg/cm2, 
24 and 72 hr: 
+ 
(nanosized 
anatase 
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Citatio
n 
Nanoparticle Cell type Physico-
chemical 
Characterizatio
n 
Cytotoxici
ty 
Comet Micronucleu
s assay 
<5 nm µm, anatase: 
5.5 µm 
and 72 hr) 
: + 
80,100 
µg/cm2. 
anatase lowest 
dose = 10 
µg/cm2 
 
only: 10 and 
60 µg/cm2 : 
72 hr) 
Kang 
et al., 
2008 
Degussa 
P25: Mean 
size 
approximatel
y 30 nm, a 
mixture of 
anatase 70–
85% and 
rutile 15-
30% 
Peripheral 
Blood 
Lymphocyt
es 
N/A Trypan 
blue: 20 
µg/ml at 
48 hr; 50 
and 100 
µg/ml at 
12, 24, 48 
hr: + 
+: dose and 
time 
dependent at 
all 
concentration
s and time 
points 
+: dose 
dependent 
increase at 
all 
concentratio
ns 
 
Park et 
al., 
2008 
 
Degussa P25 
TiO2 : Mean 
size = 21 
nm, a 
mixture of 
anatase 70–
85% and 
rutile 15-
30% 
 
BEAS-2B 
 
N/A 
 
MTT 
assay : + 
at 5, 10, 
20, and 40 
µg/ml @ 
24, 48, 72, 
and 96 hr 
 
N/A 
 
N/A 
Shukla 
et al., 
2010 
TiO2 : 
99.7% 
anatase 
A431 
(epidermal 
cell line) 
TEM 
DLS: 124.9 nm 
in H20, 171.4 
in DMEM w/ 
10% FBS 
MTT and 
NR : + @ 
8 and 80 
µg/ml 
after 48 hr 
+ : 8 and 80 
µg/ml after 6 
h in both 
alkaline and 
Fpg comet 
assay 
+ : 0.8 – 80 
µg/ml after 
6 h exposure 
Hamze
h et al., 
2013 
MTI: 
anatase, P25: 
rutile/anatas
e, 
nanofilament
: rutle, vive: 
rutile, 
allosperse-
A: polymer-
coated 
V79 
(Chinese 
hamster 
lung 
fibroblast) 
DLS: MTI: 460 
nm, -12 mV, 
P25: 400 nm, -
12 mV, 
Nanofilament: 
420 nm, -12 
mV, Coated: 
600 nm, -19 
mV 
MTI: + 
(24, 48 h) 
P25: + 
(24, 48 h) 
Nanofilam
ent: + (24, 
48 h) 
10 and 100 
mg/L 
+ (MTI, P25, 
nanofilament) 
N/A 
Srivast
ava et 
al., 
2013 
TiO2 
(Sigma-
Aldrich) 
A549 DLS: 434.1 
nm, -7.83 mV 
+ (10-100 
µg/ml) @ 
24 and 48 
h with 
MTT, 
LDH 
N/A + (24 h, 10 
and 50 
µg/ml) 
Woodr
uff et 
al., 
2012 
TiO2 TK6 cells Synthesized at 
University of 
Arkansas 
- - N/A 
Guicha
rd et 
al., 
2012 
TiO2 
anatase, 
TiO2 rutile, 
P25 
(anatase/rutil
e) 
SHE 
(Syrian 
hamster 
embryo) 
cells 
TiO2 rutile: 62 
± 24 nm 
TiO2 anatase: 
14 ±4 nm 
P25: 25 ± 6 nm 
DLS: 300-700 
nm 
+ + (except 
rutile) 
- 
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Citatio
n 
Nanoparticle Cell type Physico-
chemical 
Characterizatio
n 
Cytotoxici
ty 
Comet Micronucleu
s assay 
Magdo
lenova 
et al., 
2012 
P25 
(anatase/rutil
e) 
TK6 
COS-1 
(monkey 
kidney 
fibroblast 
cells) 
EUE 
(human 
embryonic 
epithelial 
cells) 
Two dispersion 
protocols (DP1 
and DP2): 
RPMI 1640 + 
10% FBS: DP1 
= 102 ± 15 nm 
and 285 ± 67 
nm. DP2 = 779 
± 382 nm. 
DMEM + 10% 
FBS: DP1 = 
112 ± 20 nm 
and 296 ± 55 
nm. DP2 = 752 
± 397 nm 
- - TK6 
+ COS-1 
(with DP-2 @ 
75 µg/cm2) 
+ EUE (with 
DP-2 @ 75 
µg/cm2) 
N/A 
Toyoo
ka et 
al., 
2012 
5 nm anatase 
(Sigma-
Aldrich) 
A549 250-650 nm 
(378 average) 
N/A N/A N/A 
Shukla 
et al., 
2013 
TiO2 anatase HepG2 N/A + + + 
Jugan 
et al., 
2012 
TiO2 
anatase/rutil
e (12-140 
nm) 
A549 N/A N/A + + 
Wang 
et al., 
2011 
TiO2 
anatase 
Chinese 
hamster 
ovary cells 
(CHO-K1) 
TEM: 
aggregated in 
medium 
- - N/A 
Kang 
et al., 
2011 
TiO2 (100 
nm) 
peripheral 
blood 
lymph 
N/A 
+ slight 
decrease 
w/o UV-
A, + big 
decrease 
 
+ (w/ UV-A) 
- (w/o 
UV-A) 
N/A 
Di 
Virgili
o et al., 
2010 
TiO2 (20 ± 7 
nm)  CHO-K1 BET 
+ (24 h)  
Neutral 
Red : 100 
µg/ml 
MTT : 5-
100 µg/ml 
N/A + (0.5 and 1 µg/ml) 
a for a further review on general toxicological studies of titanium dioxide nanoparticles, see Iavicoli et al., 2012. 
b N/A = did not find values in text 
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Supplemental Figure 6. SDS-PAGE electrophoresis gel of proteins adsorbed 
onto the surface of TiO2 nanoparticles after suspension in three treatment 
media for 24 h at 37C. Ladder: Fermentas PageRulerTM Plus Protein Ladder, 
1: TiO2 nanoparticles in KB medium, 2: KB medium alone, 3: TiO2 
nanoparticles in DM medium, 4: DM medium alone, 5: TiO2 nanoparticles in 
KF medium, 6: KF medium alone. 
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APPENDIX III 
                 CHAPTER 3: SUPPORTING INFORMATION 
 
 
 
Supplemental Figure 10. Transmission electron microscpy image of 
human dermal fibroblast treated with nano-TiO2 for 24 h at 10 µg/ml. 
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Supplemental Table 4. Average # of Nuclei/Well.  Data 
expressed as mean  ± SD of three independent experiments. 
  
 
Concentration (µg/ml) 
 0 1 3 
pH2AX 3523 ± 713 2848  ± 763 3233  ± 715 
pATM 4869  ± 261 5636  ± 403 4834  ± 126 
pChk2  3444 ± 773 3915 ± 668  3964 ± 664  
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APPENDIX IV 
                CHAPTER 4: SUPPORTING INFORMATION 
 
 
kDa 
250 
130 
95 
72 
55 
36 
28 
Ladder       1       2      3       4 
Supplemental Figure 11. Proteins adsorbed to the surface of nano-TiO2 in DB or DF 
medium after 24 h as visualized by 1D SDS-PAGE gel electrophoresis.  Nano-TiO2 were 
dispersed in treatment medium and incubated for 24 h.  After incubation, nano-TiO2 were 
centrifuged and washed with PBS.  The PBS was aspirated and nano-TiO2 was mixed 
with SDS-PAGE buffer for 10 minutes at 95°C to allow for adsorbed proteins on the 
surface of nano-TiO2 bind to buffer.   Ladder) Fermentas PageRuler™ protein ladder, (1) 
nano-TiO2 in DB medium, (2) DB medium alone, (3) nano-TiO2 in DF medium, (4) DF 
medium alone. 
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Supplemental Figure 12. Cell viability was evaluated by Cell-Titer Blue® after exposure 
to nanoparticles at 0.003 – 100 µg/ml in half log increments.  A 24-h exposure to silver 
nitrate (AgNO3) at 0.3 to 100 µg/ml in half log increments was used as a positive control.  
*p < 0.05, n = 3. 
* 
* 
* * * * 
DB#
DF#
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Supplemental Figure 13. Fold changes in expression of cellular stress-response 
luciferase-reporter genes for (A) NFkB and (B) AP1 exposed to the positive control 
hydroquinone (HQ) for 24 h in HepG2 cells at half log concentrations. *p < 0.05, n = 3. 
A" B"
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    Characteristic                  ````````               Result 
Primary Particle Size 27.5 nm 
Size Range  14.6-64.1 nm 
Surface Area 49 m2/g 
% Purity 95.1% 
Crystal Form 86% anatase/14%rutile  
Supplemental Table 5. Physical characteristics of  nano-TiO2a 
aSize, surface area, purity, and crystal form of P25 TiO2 received 
from manufacturer were measured independently. Approximately 
150 dry particles were examined by TEM.  Data from the 
University of Kentucky (see Materials and Methods). 
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Supplemental Table 6. Polydispersion index and zeta potential of nano-TiO2 
in KB and KFa 
 Treatment 
Medium 
Concentration 
(µg/ml) 
Polydispersion Index 
 
Zeta Potential 
 (mV) 
DB 
0 0.18 ± 0.03 -5.42 ± 1.90 
10 0.31 ± 0.02 -8.11 ± 2.18 
50 0.31 ± 0.08 -8.64 ± 0.84 
100 0.26 ± 0.05 -7.22 ± 1.20 
 
DF 
0 0.18 ± 0.05 -6.48 ± 1.32 
10 0.34 ± 0.05 -6.66 ± 0.48 
50 0.32 ± 0.05 -8.48 ± 2.08 
100   0.26 ± 0.07 -7.53 ± 0.82 
aData expressed as mean  ± SEM of three independent experiments. 
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Concentration (µg/ml) 
 
NP  0 1 3 
DB 4270 ± 1220 3957 ± 853 4297 ± 733 
DF 3816 ± 405 3945 ± 479 3331 ± 528 
Supplemental Table 7. Average number of Nuclei/Wella 
aData expressed as mean  ± SD of three independent experiments. 
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KB KB-Plus 
KGM medium KGM medium 
1.08 g/L glucose 4.50 g/L glucose 
1.50 mM KCl 5.37 mM KCl 
Supplemental Table 8. KB and KB-Plus medium 
composition 
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